{"content":"<li class=\"n-box-item date-title\" data-end=\"1574398799\" data-start=\"1574312400\" data-txt=\"Monday, December 23, 2019\">Thursday, November 21, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3521425\" data-ts=\"1574379245\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSDT\" target=\"_blank\">HSDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521425-heliusminus-11-after-announcing-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Helius -11% after announcing share offering</a></h4><ul>   <li>Helius Medical Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HSDT' title='Helius Medical Technologies, Inc.'>HSDT</a>) is <font color=\"red\">10.9% lower</font> after-hours following its announcement of a <a href=\"https://seekingalpha.com/pr/17708138-helius-medical-technologies-inc-announces-proposed-public-offering\" target=\"_blank\">proposed public offering</a>.</li>    <li>It's not set size or other terms.</li>    <li>H.C. Wainwright is sole book-runner, with Haywood Securities acting as co-manager. Underwriters are expected to get a 30-day greenshoe option for up to an additional 15% of shares.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3521425\" data-linked=\"Helius -11% after announcing share offering\" data-tweet=\"$HSDT - Helius -11% after announcing share offering https://seekingalpha.com/news/3521425-heliusminus-11-after-announcing-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3521425-heliusminus-11-after-announcing-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521419\" data-ts=\"1574377241\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TELNY\" target=\"_blank\">TELNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521419-telenor-said-to-offer-156_7m-shares-of-veon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telenor said to offer 156.7M shares of VEON</a></h4><ul>   <li>Telenor (<a href='https://seekingalpha.com/symbol/TELNY' title='Telenor ASA'>OTCPK:TELNY</a>) is reportedly offering 156.7M ADRs of VEON (NASDAQ:<a href='https://seekingalpha.com/symbol/VEON' title='VEON Ltd.'>VEON</a>) in a cleanup trade, Bloomberg reports.</li>    <li>That offering, via Citi, is set to come at $2.32 to $2.35 each - a discount of 3.7%-4.9% from the closing price.</li>    <li>VEON is <font color=\"red\">down 1.6%</font> after-hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521419\" data-linked=\"Telenor said to offer 156.7M shares of VEON\" data-tweet=\"$TELNY $VEON $TELNF - Telenor said to offer 156.7M shares of VEON https://seekingalpha.com/news/3521419-telenor-said-to-offer-156_7m-shares-of-veon?source=tweet\" data-url=\"https://seekingalpha.com/news/3521419-telenor-said-to-offer-156_7m-shares-of-veon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521411\" data-ts=\"1574375494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDOG\" target=\"_blank\">DDOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521411-datadog-announces-security-monitoring-product-sharesplus-1_9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Datadog announces Security Monitoring product; shares +1.9%</a></h4><ul><li>Datadog (NASDAQ:<a href='https://seekingalpha.com/symbol/DDOG' title='Datadog, Inc.'>DDOG</a>) <a href=\"https://seekingalpha.com/pr/17708158-datadog-announces-security-monitoring\" target=\"_blank\">announces</a> the new product that \"enables real-time threat detection across the entire stack and deeper collaboration between security, developers, and operations teams.\"</li><li>Datadog Security Monitoring includes observability data, out-of-the-box and editable detection rules, real-time detection, and collaboration tools.</li><li>The company will demonstrate the product at AWS re:Invent in Las Vegas from December 2 to December 5.</li><li>DDOG shares are <font color=\"green\">up 1.9%</font> after hours to $40.80.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521411\" data-linked=\"Datadog announces Security Monitoring product; shares +1.9%\" data-tweet=\"$DDOG - Datadog announces Security Monitoring product; shares +1.9% https://seekingalpha.com/news/3521411-datadog-announces-security-monitoring-product-sharesplus-1_9?source=tweet\" data-url=\"https://seekingalpha.com/news/3521411-datadog-announces-security-monitoring-product-sharesplus-1_9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521409\" data-ts=\"1574375355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521409-ooma-jwn-lob-and-sum-among-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OOMA, JWN, LOB and SUM among after-hours movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/OOMA' title='Ooma, Inc.'>OOMA</a> <font color=\"green\">+16.6%</font>. <a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom, Inc.'>JWN</a> <font color=\"green\">+8.5%</font>. <a href='https://seekingalpha.com/symbol/PCQ' title='PIMCO California Municipal Income Fund'>PCQ</a> <font color=\"green\">+8.5%</font>. <a href='https://seekingalpha.com/symbol/SCVL' title='Shoe Carnival, Inc.'>SCVL</a> <font color=\"green\">+7.7%</font>. <a href='https://seekingalpha.com/symbol/SPLK' title='Splunk Inc.'>SPLK</a> <font color=\"green\">+5.6%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/PSTG' title='Pure Storage, Inc.'>PSTG</a> <font color=\"red\">-23.4%</font>. <a href='https://seekingalpha.com/symbol/LOB' title='Live Oak Bancshares, Inc.'>LOB</a> <font color=\"red\">-8.5%</font>. <a href='https://seekingalpha.com/symbol/SUM' title='Summit Materials, Inc.'>SUM</a> <font color=\"red\">-5.8%</font>. <a href='https://seekingalpha.com/symbol/ABCB' title='Ameris Bancorp'>ABCB</a> <font color=\"red\">-4.9%</font>. <a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color=\"red\">-4.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521409\" data-linked=\"OOMA, JWN, LOB and SUM among after-hours movers\" data-tweet=\"$OOMA $JWN $PCQ - OOMA, JWN, LOB and SUM among after-hours movers https://seekingalpha.com/news/3521409-ooma-jwn-lob-and-sum-among-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3521409-ooma-jwn-lob-and-sum-among-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521403\" data-ts=\"1574374482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IIIV\" target=\"_blank\">IIIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521403-i3-verticals-eps-beats-0_01\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">i3 Verticals EPS beats by $0.01</a></h4><ul><li>i3 Verticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IIIV' title='i3 Verticals, Inc.'>IIIV</a>): Q4 Non-GAAP EPS of $0.24 <font color=\"green\">beats by $0.01</font>; GAAP EPS of -$0.07 <font color=\"red\">misses by $0.15</font>.</li><li>Revenue of $108.56M (+29.2% Y/Y)</li><li>Shares <font color=\"green\">+3.14%</font> AH.</li><li><a href=\"https://seekingalpha.com/pr/17708338-i3-verticals-reports-fourth-quarter-full-fiscal-year-2019-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3521403\" data-linked=\"i3 Verticals EPS beats by $0.01\" data-tweet=\"$IIIV - i3 Verticals EPS beats by $0.01 https://seekingalpha.com/news/3521403-i3-verticals-eps-beats-0_01?source=tweet\" data-url=\"https://seekingalpha.com/news/3521403-i3-verticals-eps-beats-0_01\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521396\" data-ts=\"1574373907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521396-marin-softwareplus-37-on-perfect-audience-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marin Software +37% on Perfect Audience sale</a></h4><ul><li>Marin Software (NASDAQ:<a href='https://seekingalpha.com/symbol/MRIN' title='Marin Software Incorporated'>MRIN</a>) <a href=\"https://seekingalpha.com/pr/17708224-marin-software-announces-sale-perfect-audience\" target=\"_blank\">completes</a> the sale of its Perfect Audience business to SharpSpring (NASDAQ:<a href='https://seekingalpha.com/symbol/SHSP' title='SharpSpring, Inc.'>SHSP</a>).</li><li>The transaction has a net cash purchase price of $4.6M before transaction costs.</li><li>Marin updates its Q4 outlook to revenue of $9.9-10.4M and loss from operations of $3.9-3.4M.</li><li>Marin shares are <font color=\"green\">up 37.4%</font> after hours to $2.37.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521396\" data-linked=\"Marin Software +37% on Perfect Audience sale\" data-tweet=\"$MRIN $SHSP - Marin Software +37% on Perfect Audience sale https://seekingalpha.com/news/3521396-marin-softwareplus-37-on-perfect-audience-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3521396-marin-softwareplus-37-on-perfect-audience-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521389\" data-ts=\"1574373652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNNT\" target=\"_blank\">PNNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521389-pennantpark-investment-q4-net-investment-income-falls\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PennantPark Investment Q4 net investment income falls</a></h4><ul><li>PennantPark Investment (NASDAQ:<a href='https://seekingalpha.com/symbol/PNNT' title='PennantPark Investment'>PNNT</a>)<a href=\"https://seekingalpha.com/pr/17708185-pennantpark-investment-corporation-announces-financial-results-fourth-quarter-fiscal-year\" target=\"_blank\"> investment income </a>for the quarter ended Sept. 30, 2019 was $27.9M up from $27.6M in the year-ago quarter.</li><li>Fiscal Q4 net investment income of $9.6M, or 14 cents per share, fell from $14.0M, or 20 cents per share, in the year-earlier quarter.</li><li>Q4 core net investment income was 17 cents per share.</li><li>Net asset value per share of $8.68 at Sept. 30, 2019 fell from $9.11 at Sept. 30, 2018.</li><li>Q4 net change in net assets resulting from operations were $8.2M, or 13 cents per share, compared with $12.5M, or 18 cents per share, in Q4 2018,  primarily due to a lower yielding portfolio, depreciation and net realized losses on our investments, and credit facility amendment and debt issuance costs.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3521342-pennantpark-investment-misses-total-investment-income\" target=\"_blank\">PennantPark Investment misses on total investment income</a> (Nov. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3521389\" data-linked=\"PennantPark Investment Q4 net investment income falls\" data-tweet=\"$PNNT - PennantPark Investment Q4 net investment income falls https://seekingalpha.com/news/3521389-pennantpark-investment-q4-net-investment-income-falls?source=tweet\" data-url=\"https://seekingalpha.com/news/3521389-pennantpark-investment-q4-net-investment-income-falls\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521381\" data-ts=\"1574372463\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTG\" target=\"_blank\">PSTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521381-pure-storageminus-23-after-revenue-miss-weak-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pure Storage -23% after revenue miss, weak outlook</a></h4><ul><li>Pure Storage (NYSE:<a href='https://seekingalpha.com/symbol/PSTG' title='Pure Storage, Inc.'>PSTG</a>)<font color=\"red\"> plunges 23.2%</font> after the <a href=\"https://seekingalpha.com/news/3521338-pure-storage-eps-beats-0_04-misses-revenue\" target=\"_blank\">Q3 report</a> missed on revenue and guided downside Q4 sales of $484-496M versus the $512.17M consensus. Q4 margin forecasts have gross from 67.5-70.5% and operating from 10-14%.</li><li>New CFO: Kevan Krysler will become the CFO early next month, joining PSTG from a role as VMware's SVP of Finance and Chief Accounting Officer.</li><li>Q3 gross margin was 71.7% compared to 68.1% in last year's quarter and the 67.9% consensus. Product gross margin was 73% (last year: 68.1%) and support subscription was 67.5% (last year: 68.1%).</li><li>Operating margin was 6.8%, down from last year's 9.1%.</li><li>The FY outlook sees revenue of $1.64-1.65B (consensus: $1.68B), gross margin of 69.2-70.1%, and operating margin of 2.6-3.9%.</li><li>Earnings call starts at 5 PM ET with a webcast <a href=\"https://c212.net/c/link/?t=0&amp;l=en&amp;o=2650983-1&amp;h=3497123580&amp;u=http%3A%2F%2Finvestor.purestorage.com%2F&amp;a=investor.purestorage.com\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17708189-pure-storage-announces-third-quarter-fiscal-2020-financial-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521381\" data-linked=\"Pure Storage -23% after revenue miss, weak outlook\" data-tweet=\"$PSTG - Pure Storage -23% after revenue miss, weak outlook https://seekingalpha.com/news/3521381-pure-storageminus-23-after-revenue-miss-weak-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3521381-pure-storageminus-23-after-revenue-miss-weak-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521376\" data-ts=\"1574372024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OOMA\" target=\"_blank\">OOMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521376-oomaplus-3_1-amid-surprise-q3-adjusted-profit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ooma +3.1% amid surprise Q3 adjusted profit</a></h4><ul>   <li>Ooma (NYSE:<a href='https://seekingalpha.com/symbol/OOMA' title='Ooma, Inc.'>OOMA</a>) is <font color=\"green\">up 3.1%</font> in light postmarket trade after <a href=\"https://seekingalpha.com/news/3521358-ooma-eps-beats-0_06-beats-revenue\" target=\"_blank\">Q3 earnings</a> that resulted in a surprise non-GAAP profit.</li>    <li>Revenues rose 21.5% thanks to gains in core subscriptions (now making up 92% of the total revenue).</li>    <li>Gross profit rose 9.8% to $22M.</li>    <li>Net loss widened on a GAAP basis to $6.78M (from a year-ago loss of $3.49M) amid higher operating expenses and a $3.1M restructuring charge.</li>    <li>But on a non-GAAP basis the company logged $0.1M in net income, vs. a year-ago loss of $0.5M.</li>    <li>Revenue breakout: Subscription and services, $36.5M (up 22.5%); Product and other, $3.1M (up 10.4%).</li>    <li>For Q4, it's guiding to revenue of $39.6M-$40.3M (above consensus for $39M) and EPS of $0.00 to $0.02 (above expectations for -$0.07).</li>    <li><a href=\"https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&amp;referrer=https%3A%2F%2Finvestors.ooma.com%2Finvestors%2Foverview%2Fdefault.aspx&amp;eventid=2079142&amp;sessionid=1&amp;key=5EEC15A4932F00034FDCE557FDB51975&amp;regTag=&amp;sourcepage=register\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17708213-ooma-reports-third-quarter-fiscal-2020-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3521376\" data-linked=\"Ooma +3.1% amid surprise Q3 adjusted profit\" data-tweet=\"$OOMA - Ooma +3.1% amid surprise Q3 adjusted profit https://seekingalpha.com/news/3521376-oomaplus-3_1-amid-surprise-q3-adjusted-profit?source=tweet\" data-url=\"https://seekingalpha.com/news/3521376-oomaplus-3_1-amid-surprise-q3-adjusted-profit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521375\" data-ts=\"1574371931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAVM\" target=\"_blank\">PAVM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521375-pavmed-eps-beats-0_01\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PAVmed EPS beats by $0.01</a></h4><ul><li>PAVmed (NASDAQ:<a href='https://seekingalpha.com/symbol/PAVM' title='PAVmed Inc.'>PAVM</a>): Q3 Non-GAAP EPS of -$0.09 <font color=\"green\">beats by $0.01</font>; GAAP EPS of -$0.10.</li><li>Cash and equivalents of $4.1M</li><li>Shares <font color=\"green\">+11.68%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17708145-pavmed-reports-third-quarter-2019-financial-results-provides-business-update\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3521375\" data-linked=\"PAVmed EPS beats by $0.01\" data-tweet=\"$PAVM - PAVmed EPS beats by $0.01 https://seekingalpha.com/news/3521375-pavmed-eps-beats-0_01?source=tweet\" data-url=\"https://seekingalpha.com/news/3521375-pavmed-eps-beats-0_01\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521370\" data-ts=\"1574371632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WSM\" target=\"_blank\">WSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521370-williams-sonoma-bid-down-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Williams-Sonoma bid down after earnings</a></h4><ul>        <li>Williams-Sonoma (NYSE:<a href='https://seekingalpha.com/symbol/WSM' title='Williams-Sonoma, Inc.'>WSM</a>) falls in AH trading even though comparable sales rose 5.5% in <a href=\"https://seekingalpha.com/pr/17708201-williams-sonoma-inc-reports-strong-results-third-quarter-2019\" target=\"_blank\">Q3</a> to top the consensus expectation for a gain of 4.9%. The West Elm business impressed again with a 14.1% comp for the quarter.</li>   <li>Operating margin came in at 7.6% of sales, level with last year's mark.</li>    <li>The retailer sees FY20 revenue of $5.77B to $5.90B vs. $5.84B consensus and FY20 EPS vs. $4.66 to $4.80 prior and $4.74 consensus.</li>    <li>CEO update: \"In a fragmented home furnishings industry, it is hard to overstate how important it has been for us to continually evolve to stay ahead of the pack and remain at the forefront of driving profitable growth. Importantly, our digital-first model is a key component of our success.\"</li>  <li>WSM <font color=\"red\">-5.45%</font> AH to $65.00.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3521354-williams-sonoma-eps-line-beats-revenue\" target=\"_blank\">Williams-Sonoma EPS in-line, beats on revenue</a> (Nov. 21)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521370\" data-linked=\"Williams-Sonoma bid down after earnings\" data-tweet=\"$WSM - Williams-Sonoma bid down after earnings https://seekingalpha.com/news/3521370-williams-sonoma-bid-down-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3521370-williams-sonoma-bid-down-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521369\" data-ts=\"1574371624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTU\" target=\"_blank\">INTU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521369-intuitminus-1_4-after-downside-earnings-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intuit -1.4% after downside earnings outlook</a></h4><ul><li>Intuit (NASDAQ:<a href='https://seekingalpha.com/symbol/INTU' title='Intuit Inc.'>INTU</a>) <font color=\"red\">falls 1.4%</font> after <a href=\"https://seekingalpha.com/news/3521328-intuit-eps-beats-0_16-beats-revenue\" target=\"_blank\">Q1 beats </a>arrived with mixed Q2 guidance, which sees downside EPS of $1.00-1.03 (consensus: $1.16). Revenue growth is seen between 11 and 13% for roughly $1.67-1.7B (consensus: $1.66B).</li><li>The company reiterates its inline FY outlook with revenue of $7.44-7.54B and EPS of $7.50-7.60.</li><li>Small Business and Self-Employed revenue rose 15% Y/Y in Q1 to $1B. Small Business Ecosystem increased 35% and Consumer Group grew 11% to $100M.</li><li>Earnings call starts at 4:30 PM ET with a webcast <a href=\"http://investors.intuit.com/Events/default.aspx\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17708140-intuit-grows-total-revenue-15-percent-first-quarter-small-business-online-ecosystem-revenue\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521369\" data-linked=\"Intuit -1.4% after downside earnings outlook\" data-tweet=\"$INTU - Intuit -1.4% after downside earnings outlook https://seekingalpha.com/news/3521369-intuitminus-1_4-after-downside-earnings-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3521369-intuitminus-1_4-after-downside-earnings-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521366\" data-ts=\"1574371347\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521366-ge-shares-hit-highest-mark-since-october-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE shares hit highest mark since October 2018</a></h4><ul><li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric Company'>GE</a> <font color='green'>+1.2%</font>) rallied to touch its <a href=\"https://finance.yahoo.com/news/ge-rises-2019-high-extending-202017300.html\" target=\"_blank\">highest level in more than a year</a> in mid-afternoon before pulling back a bit.</li><li>The stock has <a href=\"https://www.marketwatch.com/story/ges-stock-surges-toward-13-month-high-to-pace-gains-of-its-industrial-peers-over-the-past-3-months-2019-11-21\" target=\"_blank\">run up 17%</a> since GE's Q3 earnings report prior to the Oct. 30 open, and it is the best performer of the 69 stocks comprising the SPDR Industrial Select Sector ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLI' title='Industrial Select Sector SPDR ETF'>XLI</a>) over the past month with a 31% gain as well as during the past three months with a 41% jump.</li><li>GE's market cap crossed back above $100B, although it remains a far cry from its 2000 peak of nearly $600B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521366\" data-linked=\"GE shares hit highest mark since October 2018\" data-tweet=\"$GE $XLI - GE shares hit highest mark since October 2018 https://seekingalpha.com/news/3521366-ge-shares-hit-highest-mark-since-october-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3521366-ge-shares-hit-highest-mark-since-october-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>73&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521363\" data-ts=\"1574371294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPS\" target=\"_blank\">GPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521363-gap-gains-after-topping-estimates-holding-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gap gains after topping estimates, holding guidance</a></h4><ul>   <li>Gap (NYSE:<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a>) beat on the top and bottom line, but comp sales slipped 4%, a tick more than the consensus 3.9% drop expected. Comp sales fell 4% at Old Navy and 7% at Gap Global.</li>  <li>Gross margin was down 90 bps to 39.0% of sales during the quarter. Adjusted operating margin fell 140 bps to 7.5% of sales.</li>    <li>Looking ahead, Gap sees comparable sales down at a low single digit rate for the full year and expects EPS to land in a range of $1.70 to $1.75 vs. $1.70 to $1.75 prior view and $1.74 consensus.</li>  <li>Shares of Gap are <font color=\"green\">up 3.56%</font> in AH trading to $16.83.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3521356-gap-eps-beats-0_02-beats-revenue\" target=\"_blank\">Gap EPS beats by $0.02, beats on revenue</a> (Nov. 21)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3521363\" data-linked=\"Gap gains after topping estimates, holding guidance\" data-tweet=\"$GPS - Gap gains after topping estimates, holding guidance https://seekingalpha.com/news/3521363-gap-gains-after-topping-estimates-holding-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3521363-gap-gains-after-topping-estimates-holding-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521356\" data-ts=\"1574371033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPS\" target=\"_blank\">GPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521356-gap-eps-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gap EPS beats by $0.02, beats on revenue</a></h4><ul><li>Gap (NYSE:<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a>): Q3 Non-GAAP EPS of $0.53 <font color=\"green\">beats by $0.02</font>; GAAP EPS of $0.37 <font color=\"red\">misses by $0.14</font>.</li><li>Revenue of $4B (-2.2% Y/Y) <font color=\"green\">beats by $40M</font>.</li><li>Shares <font color=\"green\">+5.06%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17708208-gap-inc-reports-third-quarter-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3521356\" data-linked=\"Gap EPS beats by $0.02, beats on revenue\" data-tweet=\"$GPS - Gap EPS beats by $0.02, beats on revenue https://seekingalpha.com/news/3521356-gap-eps-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3521356-gap-eps-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521346\" data-ts=\"1574370870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLK\" target=\"_blank\">SPLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521346-splunk-beats-raises-fy-revenue-view-sharesplus-5_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Splunk beats, raises FY revenue view; shares +5.6%</a></h4><ul><li>Splunk (NASDAQ:<a href='https://seekingalpha.com/symbol/SPLK' title='Splunk Inc.'>SPLK</a>) <font color=\"green\">+5.6%</font> beats <a href=\"https://seekingalpha.com/news/3521330-splunk-eps-beats-0_04-beats-revenue\" target=\"_blank\">Q3 estimates</a> with revenue up 30% Y/Y. The upside Q4 outlook sees revenue of $780M versus the $767.71M consensus.</li><li>Q3 software revenue was up 40% Y/Y to $454M.</li><li>Total ARR was $1.4B, up 53%.</li><li>Operating cash flow was -$135M and FCF was -$162M.</li><li>Splunk signed 440 new enterprise customers in the quarter. New and expanded customers included Airbus (<a href='https://seekingalpha.com/symbol/EADSF' title='Airbus SE'>OTCPK:EADSF</a>), Anaplan (NYSE:<a href='https://seekingalpha.com/symbol/PLAN' title='Anaplan, Inc.'>PLAN</a>), and Chegg (NYSE:<a href='https://seekingalpha.com/symbol/CHGG' title='Chegg, Inc.'>CHGG</a>).</li><li>The FY guidance raises revenue from $2.3B to $2.35B and maintains an operating margin outlook of 14%.</li><li>Earnings call starts at 4:30 PM ET with a webcast<a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Finvestors.splunk.com%2Fevents-presentations&amp;esheet=52133315&amp;newsitemid=20191121005873&amp;lan=en-US&amp;anchor=http%3A%2F%2Finvestors.splunk.com%2Fevents-presentations&amp;index=16&amp;md5=5f3510015b2ae06790faf449a1ba1198\" target=\"_blank\"> here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17708150-splunk-inc-announces-fiscal-third-quarter-2020-financial-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521346\" data-linked=\"Splunk beats, raises FY revenue view; shares +5.6%\" data-tweet=\"$SPLK $SPLK $EADSF - Splunk beats, raises FY revenue view; shares +5.6% https://seekingalpha.com/news/3521346-splunk-beats-raises-fy-revenue-view-sharesplus-5_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3521346-splunk-beats-raises-fy-revenue-view-sharesplus-5_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521345\" data-ts=\"1574370737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521345-nordstromplus-6-after-off-price-sales-turn-positive\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordstrom +6% after off-price sales turn positive</a></h4><ul> <li>Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom, Inc.'>JWN</a>) reports full-price sales fell 4.1% in <a href=\"https://seekingalpha.com/pr/17708156-nordstrom-reports-third-quarter-2019-earnings\" target=\"_blank\">Q3</a> and off-price sales rose 1.2%.</li> <li>Digital sales rose 7% during the quarter and as a percentage of total sales accounted for 34%.</li> <li>Gross margin came in at 34.3% of sales vs. 34.0% consensus and 33.3% a year ago.</li> <li>Management update: \"Our third quarter earnings exceeded expectations, demonstrating substantial progress in the delivery of our strategy and strength of our operating discipline. Through our customer focus, we drove broad-based improvement in top-line trends. The consistent strength of our inventory and expense execution contributed to increased profitability for the quarter.\"</li> <li>Looking ahead, Nordstrom anticipates full-year revenue to fall 2% and EPS of $3.25 to $3.30 vs. $3.26 consensus and $3.25 to $3.50 prior outlook.</li> <li>Shares of Nordstrom are <font color=\"green\">up 5.54%</font> in AH trading to $36.20.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3521337-nordstrom-eps-beats-0_16-beats-revenue\" target=\"_blank\">Nordstrom EPS beats by $0.16, beats on revenue</a> (Nov. 21)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521345\" data-linked=\"Nordstrom +6% after off-price sales turn positive\" data-tweet=\"$JWN - Nordstrom +6% after off-price sales turn positive https://seekingalpha.com/news/3521345-nordstromplus-6-after-off-price-sales-turn-positive?source=tweet\" data-url=\"https://seekingalpha.com/news/3521345-nordstromplus-6-after-off-price-sales-turn-positive\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521344\" data-ts=\"1574370724\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCVL\" target=\"_blank\">SCVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521344-shoe-carnival-eps-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shoe Carnival EPS beats by $0.05, beats on revenue</a></h4><ul><li>Shoe Carnival (NASDAQ:<a href='https://seekingalpha.com/symbol/SCVL' title='Shoe Carnival, Inc.'>SCVL</a>): Q3 GAAP EPS of $0.94 <font color=\"green\">beats by $0.05</font>.</li><li>Revenue of $274.65M (+2.0% Y/Y) <font color=\"green\">beats by $1.45M</font>.</li><li>Shares <font color=\"green\">+4.85%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17708175-shoe-carnival-reports-third-quarter-fiscal-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3521344\" data-linked=\"Shoe Carnival EPS beats by $0.05, beats on revenue\" data-tweet=\"$SCVL - Shoe Carnival EPS beats by $0.05, beats on revenue https://seekingalpha.com/news/3521344-shoe-carnival-eps-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3521344-shoe-carnival-eps-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521337\" data-ts=\"1574370422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521337-nordstrom-eps-beats-0_16-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordstrom EPS beats by $0.16, beats on revenue</a></h4><ul><li>Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom, Inc.'>JWN</a>): Q3 GAAP EPS of $0.81 <font color=\"green\">beats by $0.16</font>.</li><li>Revenue of $3.67B (-2.1% Y/Y) <font color=\"green\">beats by $10M</font>.</li><li>Shares <font color=\"green\">+9.27%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17708156-nordstrom-reports-third-quarter-2019-earnings\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3521337\" data-linked=\"Nordstrom EPS beats by $0.16, beats on revenue\" data-tweet=\"$JWN - Nordstrom EPS beats by $0.16, beats on revenue https://seekingalpha.com/news/3521337-nordstrom-eps-beats-0_16-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3521337-nordstrom-eps-beats-0_16-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521336\" data-ts=\"1574370419\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROST\" target=\"_blank\">ROST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521336-ross-storesplus-1-after-earnings-topper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ross Stores +1% after earnings topper</a></h4><ul>   <li>Ross Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/ROST' title='Ross Stores, Inc.'>ROST</a>) reports comparable sales increased 5% in <a href=\"https://seekingalpha.com/pr/17708144-ross-stores-reports-third-quarter-earnings-updates-fourth-quarter-guidance\" target=\"_blank\">Q3</a> on top of last year's 3% increase.</li>   <li>Operating margin was up to 12.4% of sales due to better than expected sales and merchandise margin.</li>    <li>Looking ahead, Ross Stores sees full-year EPS of $4.52 to $4.57 vs. $4.41 to $4.50 prior view and $4.51 consensus.</li>  <li>CEO update: \"As we enter this year\u2019s holiday season, we are up against multiple years of strong comparable store sales gains. In addition, we expect another fiercely competitive retail landscape, along with ongoing uncertainty surrounding the macro-economic and political environment. As such, while we hope to do better, we continue to project fourth quarter comparable store sales gains of 1% to 2% versus a 4% increase last year.\"</li> <li>Shares of Ross Stores are <font color=\"green\">up 1.06%</font> in AH trading to $112.97</li><li>Previously: <a href=\"https://seekingalpha.com/news/3521329-ross-stores-eps-beats-0_06-beats-revenue\" target=\"_blank\">Ross Stores EPS beats by $0.06, beats on revenue</a> (Nov. 21)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3521336\" data-linked=\"Ross Stores +1% after earnings topper\" data-tweet=\"$ROST - Ross Stores +1% after earnings topper https://seekingalpha.com/news/3521336-ross-storesplus-1-after-earnings-topper?source=tweet\" data-url=\"https://seekingalpha.com/news/3521336-ross-storesplus-1-after-earnings-topper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521329\" data-ts=\"1574370217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROST\" target=\"_blank\">ROST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521329-ross-stores-eps-beats-0_06-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ross Stores EPS beats by $0.06, beats on revenue</a></h4><ul><li>Ross Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/ROST' title='Ross Stores, Inc.'>ROST</a>): Q3 GAAP EPS of $1.03 <font color=\"green\">beats by $0.06</font>.</li><li>Revenue of $3.85B (+8.5% Y/Y) <font color=\"green\">beats by $80M</font>.</li><li>Shares <font color=\"green\">+3.66%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17708144-ross-stores-reports-third-quarter-earnings-updates-fourth-quarter-guidance\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3521329\" data-linked=\"Ross Stores EPS beats by $0.06, beats on revenue\" data-tweet=\"$ROST - Ross Stores EPS beats by $0.06, beats on revenue https://seekingalpha.com/news/3521329-ross-stores-eps-beats-0_06-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3521329-ross-stores-eps-beats-0_06-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521333\" data-ts=\"1574369880\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPOR\" target=\"_blank\">GPOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521333-gulfport-energy-shareholder-calls-for-board-shakeup\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gulfport Energy shareholder calls for board shakeup</a></h4><ul><li>Firefly Value Partners says it wants a seat on Gulfport Energy's (<a href='https://seekingalpha.com/symbol/GPOR' title='Gulfport Energy Corporation'>GPOR</a> <font color='red'>-2.2%</font>) board, as it <a href=\"https://www.reuters.com/article/us-gulfport-energy-sharebuybacks-firefly/hedge-fund-firefly-hits-out-at-gulfport-energys-plans-demands-board-seat-idUSKBN1XV2AP\" target=\"_blank\">criticizes the \"half-measures\"</a> it says the gas exploration and production company is taking to improve its financial performance.</li><li>GPOR <a href=\"https://seekingalpha.com/news/3520043-gulfport-energy-stop-share-buybacks-cut-jobs-houston-leave-board\" target=\"_blank\">earlier this week</a> announced job cuts, board changes and an end to its stock buyback program to focus on debt repurchases, but the stock has continued to drop, prompting Firefly - which owns a 9.9% stake in the company - to fire off a <a href=\"https://www.businesswire.com/news/home/20191121005528/en/\" target=\"_blank\">letter to the board</a> that blames the current directors for the company's failures.</li><li>GPOR said on Monday that Chairman David Houston would not stand for re-election next year and two other directors - would step down by year-end, which Firefly wants filled with one of its representatives.</li><li>GPOR says it has invited the hedge fund \"to provide criteria and/or resumes for qualified new director candidates, which they have declined to do.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3521333\" data-linked=\"Gulfport Energy shareholder calls for board shakeup\" data-tweet=\"$GPOR - Gulfport Energy shareholder calls for board shakeup https://seekingalpha.com/news/3521333-gulfport-energy-shareholder-calls-for-board-shakeup?source=tweet\" data-url=\"https://seekingalpha.com/news/3521333-gulfport-energy-shareholder-calls-for-board-shakeup\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521431\" data-ts=\"1574369292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENPH\" target=\"_blank\">ENPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521431-enphase-energy-jumps-on-news-of-insider-buying\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enphase Energy jumps on news of insider buying</a></h4><ul><li>Enphase Energy (<a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy, Inc.'>ENPH</a> <font color=\"green\">+3.9%</font>) pops in late trading after disclosing CEO and President Badri Kothandaraman and CFO Eric Branderiz each bought 10K shares today.</li><li><a href=\"https://www.streetinsider.com/SEC+Filings/Form+4+Enphase+Energy%2C+Inc.+For%3A+Nov+21+Filed+by%3A+Kothandaraman+Badrinarayanan/16166065.html\" target=\"_blank\">The CEO purchased</a> his shares at $17.69 each; he now owns more than 524K shares in the company.</li><li>The CFO also <a href=\"https://www.streetinsider.com/SEC+Filings/Form+4+Enphase+Energy%2C+Inc.+For%3A+Nov+21+Filed+by%3A+Branderiz+Eric/16166073.html\" target=\"_blank\">bought shares</a> at $17.69; he now owns 392K shares total.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521431\" data-linked=\"Enphase Energy jumps on news of insider buying\" data-tweet=\"$ENPH - Enphase Energy jumps on news of insider buying https://seekingalpha.com/news/3521431-enphase-energy-jumps-on-news-of-insider-buying?source=tweet\" data-url=\"https://seekingalpha.com/news/3521431-enphase-energy-jumps-on-news-of-insider-buying\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521315\" data-ts=\"1574366828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521315-blue-hat-interactive-entertainment-and-telenav-among-tech-gainers-cubic-and-aurora-mobile\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blue Hat Interactive Entertainment and Telenav among Tech gainers; Cubic and Aurora Mobile among losers</a></h4><ul><li><b>Gainers: </b>Blue Hat Interactive Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/BHAT' title='Fujian Blue Hat Interactive Entertainment Technology Ltd.'>BHAT</a>) <font color=\"green\">+12%</font>. Telenav (NASDAQ:<a href='https://seekingalpha.com/symbol/TNAV' title='Telenav, Inc.'>TNAV</a>) <font color=\"green\">+11%</font>. Anaplan (NYSE:<a href='https://seekingalpha.com/symbol/PLAN' title='Anaplan, Inc.'>PLAN</a>) <font color=\"green\">+8%</font>. Digital Ally (NASDAQ:<a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a>) <font color=\"green\">+8%</font>. Ceragon Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/CRNT' title='Ceragon Networks Ltd.'>CRNT</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Cubic (NYSE:<a href='https://seekingalpha.com/symbol/CUB' title='Cubic Corporation'>CUB</a>) <font color=\"red\">-19%</font>. Aurora Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/JG' title='Aurora Mobile Limited'>JG</a>) <font color=\"red\">-11%</font>. Qudian (NYSE:<a href='https://seekingalpha.com/symbol/QD' title='Qudian Inc.'>QD</a>) <font color=\"red\">-10%</font>. Internap (NASDAQ:<a href='https://seekingalpha.com/symbol/INAP' title='Internap Corporation'>INAP</a>) <font color=\"red\">-9%</font>. Communications Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/JCS' title='Communications Systems, Inc.'>JCS</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521315\" data-linked=\"Blue Hat Interactive Entertainment and Telenav among Tech gainers; Cubic and Aurora Mobile among losers\" data-tweet=\"$BHAT $TNAV $PLAN - Blue Hat Interactive Entertainment and Telenav among Tech gainers; Cubic and Aurora Mobile among losers https://seekingalpha.com/news/3521315-blue-hat-interactive-entertainment-and-telenav-among-tech-gainers-cubic-and-aurora-mobile?source=tweet\" data-url=\"https://seekingalpha.com/news/3521315-blue-hat-interactive-entertainment-and-telenav-among-tech-gainers-cubic-and-aurora-mobile\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521303\" data-ts=\"1574362841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521303-pedevco-and-rosehill-resources-among-energy-materials-gainers-seadrill-and-camber-energy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PEDEVCO and Rosehill Resources among Energy/Materials gainers; Seadrill and Camber Energy among losers</a></h4><ul><li><b>Gainers: </b>PEDEVCO (NYSEMKT:<a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a>) <font color=\"green\">+8%</font>. Rosehill Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/ROSE' title='Rosehill Resources Inc.'>ROSE</a>) <font color=\"green\">+8%</font>. Contango Oil &amp; Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a>) <font color=\"green\">+7%</font>. EnLink Midstream (NYSE:<a href='https://seekingalpha.com/symbol/ENLC' title='EnLink Midstream, LLC'>ENLC</a>) <font color=\"green\">+7%</font>. Gerdau (NYSE:<a href='https://seekingalpha.com/symbol/GGB' title='Gerdau S.A.'>GGB</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited'>SDRL</a>) <font color=\"red\">-23%</font>. Camber Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a>) <font color=\"red\">-12%</font>. Endeavour Silver (NYSE:<a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a>) <font color=\"red\">-9%</font>. BP Prudhoe Bay Royalty Trust (NYSE:<a href='https://seekingalpha.com/symbol/BPT' title='BP Prudhoe Bay Royalty Trust'>BPT</a>) <font color=\"red\">-7%</font>. Westwater Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/WWR' title='Westwater Resources, Inc.'>WWR</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521303\" data-linked=\"PEDEVCO and Rosehill Resources among Energy/Materials gainers; Seadrill and Camber Energy among losers\" data-tweet=\"$PED $ROSE $MCF - PEDEVCO and Rosehill Resources among Energy/Materials gainers; Seadrill and Camber Energy among losers https://seekingalpha.com/news/3521303-pedevco-and-rosehill-resources-among-energy-materials-gainers-seadrill-and-camber-energy?source=tweet\" data-url=\"https://seekingalpha.com/news/3521303-pedevco-and-rosehill-resources-among-energy-materials-gainers-seadrill-and-camber-energy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521296\" data-ts=\"1574360044\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521296-vivendi-ready-to-sell-20-of-mediaset-3_25-share-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivendi ready to sell 20% of Mediaset at \u20ac3.25/share - Bloomberg</a></h4><ul>   <li>Vivendi (<a href=\"http://seekingalpha.com/symbol/VIVHY\" target=\"_blank\">VIVHY</a> <font color=\"green\">+0.1%</font>) is ready to sell the 20% of Mediaset (<a href=\"http://seekingalpha.com/symbol/MDIUY\" target=\"_blank\">MDIUY</a> <font color=\"green\">+4.4%</font>) held in the Simon Fiduciaria trust, Bloomberg reports, at \u20ac3.25/share.</li>    <li>That would come as a gesture of goodwill in the contentious relationship, a source tells the news service.</li><li>Mediaset recently reportedly offered \u20ac2.77/share vs. a Vivendi counter of \u20ac3.70/share.</li>    <li>Vivendi would keep the rest of its stake in the company after such a sale, about 8.8%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521296\" data-linked=\"Vivendi ready to sell 20% of Mediaset at \u20ac3.25/share - Bloomberg\" data-tweet=\"$VIVHY $MDIUY - Vivendi ready to sell 20% of Mediaset at \u20ac3.25/share - Bloomberg https://seekingalpha.com/news/3521296-vivendi-ready-to-sell-20-of-mediaset-3_25-share-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3521296-vivendi-ready-to-sell-20-of-mediaset-3_25-share-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521294\" data-ts=\"1574359136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDR\" target=\"_blank\">MDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521294-mcdermott-defends-participation-in-russian-petrochemical-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McDermott defends participation in Russian petrochemical project</a></h4><ul><li>McDermott (<a href='https://seekingalpha.com/symbol/MDR' title='McDermott International, Inc.'>MDR</a> <font color=\"green\">+33.9%</font>) says its newly awarded contract for work on a petrochemical project in Russia, announced <a href=\"https://seekingalpha.com/pr/17701808-mcdermott-awarded-ethylene-technology-extended-basic-engineering-contract-russia-two-ethylene\" target=\"_blank\">earlier this week</a>, is <a href=\"https://www.reuters.com/article/us-russia-usa-mcdermott/u-s-based-mcdermott-says-its-participation-in-russian-petrochemical-project-is-legal-idUSKBN1XV1K0\" target=\"_blank\">in full compliance</a> with the law and does not breach international sanctions against the country.</li><li>Royal Dutch Shell (NYSE:<a href='https://seekingalpha.com/symbol/RDS.A' title='Royal Dutch Shell plc'>RDS.A</a>) (NYSE:<a href='https://seekingalpha.com/symbol/RDS.B' title='Royal Dutch Shell plc'>RDS.B</a>) pulled out of the same Baltic Coast project in April; according to Reuters, one factor behind the decision was that Gazprom (<a href='https://seekingalpha.com/symbol/GZPFY' title='Public Joint Stock Company Gazprom Neft'>OTCQX:GZPFY</a>) brought in another partner with links to businessman Arkady Rotenberg, who is on a U.S. sanctions blacklist.</li><li>MDR said this week it will provide ethylene technology and basic engineering for two ethylene crackers at what is the largest ethylene integration project in the world; it was awarded the contract by Baltic Chemical Company, which is 100% owned by RusGazDobycha.</li><li>RusGazDobycha's parent company previously was controlled by blacklisted Rotenberg, an ally of Russian Pres. Putin, but MDR says Rotenberg has since sold interests in BCC and no longer has ties to the company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521294\" data-linked=\"McDermott defends participation in Russian petrochemical project\" data-tweet=\"$MDR $MDR $RDS.A - McDermott defends participation in Russian petrochemical project https://seekingalpha.com/news/3521294-mcdermott-defends-participation-in-russian-petrochemical-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3521294-mcdermott-defends-participation-in-russian-petrochemical-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521293\" data-ts=\"1574359133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521293-ideal-power-and-capstone-turbine-among-industrial-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ideal Power and Capstone Turbine among Industrial gainers</a></h4><ul><li><b>Gainers: </b>Ideal Power (NASDAQ:<a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a>) <font color=\"green\">+9%</font>. Capstone Turbine (NASDAQ:<a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a>) <font color=\"green\">+8%</font>. Vertex Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/VTNR' title='Vertex Energy, Inc.'>VTNR</a>) <font color=\"green\">+7%</font>. Huitao Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/HHT' title='Huitao Technology Co.'>HHT</a>) <font color=\"green\">+6%</font>. LiqTech International (NASDAQ:<a href='https://seekingalpha.com/symbol/LIQT' title='LiqTech International, Inc.'>LIQT</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>BrightView (NYSE:<a href='https://seekingalpha.com/symbol/BV' title='BrightView Holdings, Inc.'>BV</a>) <font color=\"red\">-12%</font>. Babcock &amp; Wilcox Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/BW' title='Babcock & Wilcox Enterprises, Inc.'>BW</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521293\" data-linked=\"Ideal Power and Capstone Turbine among Industrial gainers\" data-tweet=\"$IPWR $CPST $VTNR - Ideal Power and Capstone Turbine among Industrial gainers https://seekingalpha.com/news/3521293-ideal-power-and-capstone-turbine-among-industrial-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3521293-ideal-power-and-capstone-turbine-among-industrial-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521291\" data-ts=\"1574358394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSSS\" target=\"_blank\">SSSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521291-sutter-rock-to-buy-back-7_6-of-shares-in-tender-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sutter Rock to buy back 7.6% of its shares in tender offer</a></h4><ul><li>Sutter Rock Capital (<a href='https://seekingalpha.com/symbol/SSSS' title='Sutter Rock Capital Corp.'>SSSS</a> <font color='red'>-1.2%</font>)<a href=\"https://seekingalpha.com/pr/17707902-sutter-rock-capital-corp-announces-expiration-preliminary-results-modified-dutch-auction\" target=\"_blank\"> expects to repurchase</a> ~1.45M shares, representing ~7.6% of its outstanding shares, at a price of $6.90 per share.</li><li>The proration factor for the tender offer is ~77.9%.</li><li>Its modified \"Dutch Auction\" tender offer expired at 5:00 PM on Nov. 20, 2019.</li><li>The purchase price of properly tendered shares represents 61.38% of net asset value per share based on the Sept. 30, 2019 NAV per share.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3507196-sutter-rock-buy-back-10m-shares-modified-dutch-auction\" target=\"_blank\">Sutter Rock to buy back up to $10M of shares in modified 'Dutch auction'</a> (Oct. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3521291\" data-linked=\"Sutter Rock to buy back 7.6% of its shares in tender offer\" data-tweet=\"$SSSS - Sutter Rock to buy back 7.6% of its shares in tender offer https://seekingalpha.com/news/3521291-sutter-rock-to-buy-back-7_6-of-shares-in-tender-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3521291-sutter-rock-to-buy-back-7_6-of-shares-in-tender-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521289\" data-ts=\"1574357816\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521289-acb-amtd-bzun-cgc-and-inmd-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ACB, AMTD, BZUN, CGC and INMD among midday movers</a></h4><ul><li><strong>Gainers: </strong>Wah Fu Education Group (NASDAQ:<a href='https://seekingalpha.com/symbol/WAFU' title='Wah Fu Education Group Limited'>WAFU</a>) <font color=\"green\">+203%</font>.</li><li>Hepion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/HEPA' title='Hepion Pharmaceuticals, Inc.'>HEPA</a>) <font color=\"green\">+48%</font>.</li><li>Stage Stores (NYSE:<a href='https://seekingalpha.com/symbol/SSI' title='Stage Stores, Inc.'>SSI</a>) <font color=\"green\">+40%</font>.</li><li>Ambow Education Holding (NYSEMKT:<a href='https://seekingalpha.com/symbol/AMBO' title='Ambow Education Holding Ltd.'>AMBO</a>) <font color=\"green\">+32%</font>.</li><li>HEXO (NYSE:<a href='https://seekingalpha.com/symbol/HEXO' title='HEXO Corp.'>HEXO</a>) <font color=\"green\">+29%</font>.</li><li>Akerna (NASDAQ:<a href='https://seekingalpha.com/symbol/KERN' title='Akerna Corp.'>KERN</a>) <font color=\"green\">+20%</font>.</li><li>Canopy Growth Corporation (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) <font color=\"green\">+20%</font>.</li><li>TD Ameritrade Holding Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a>) <font color=\"green\">+19%</font>.</li><li>Molecular Templates (NASDAQ:<a href='https://seekingalpha.com/symbol/MTEM' title='Molecular Templates, Inc.'>MTEM</a>) <font color=\"green\">+18%</font>.</li><li>Aurora Cannabis (NYSE:<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>) <font color=\"green\">+17%</font>.</li> <li><strong>Losers: </strong>GlycoMimetics (NASDAQ:<a href='https://seekingalpha.com/symbol/GLYC' title='GlycoMimetics, Inc.'>GLYC</a>) <font color=\"red\">-23%</font>.</li><li>Aurora Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/JG' title='Aurora Mobile Limited'>JG</a>) <font color=\"red\">-21%</font>.</li><li>Cubic Corporation (NYSE:<a href='https://seekingalpha.com/symbol/CUB' title='Cubic Corporation'>CUB</a>) <font color=\"red\">-20%</font>.</li><li>Karuna Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/KRTX' title='Karuna Therapeutics, Inc.'>KRTX</a>) <font color=\"red\">-19%</font>.</li><li>Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited'>SDRL</a>) <font color=\"red\">-18%</font>.</li><li>Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"red\">-17%</font>.</li><li>Baozun (NASDAQ:<a href='https://seekingalpha.com/symbol/BZUN' title='Baozun Inc.'>BZUN</a>) <font color=\"red\">-17%</font>.</li><li>Aprea Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/APRE' title='Aprea Therapeutics, Inc.'>APRE</a>) <font color=\"red\">-15%</font>.</li><li>Tonix Pharmaceuticals Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"red\">-15%</font>.</li><li>InMode (NASDAQ:<a href='https://seekingalpha.com/symbol/INMD' title='InMode Ltd.'>INMD</a>) <font color=\"red\">-16%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521289\" data-linked=\"ACB, AMTD, BZUN, CGC and INMD among midday movers\" data-tweet=\"$WAFU $HEPA $SSI - ACB, AMTD, BZUN, CGC and INMD among midday movers https://seekingalpha.com/news/3521289-acb-amtd-bzun-cgc-and-inmd-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3521289-acb-amtd-bzun-cgc-and-inmd-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521286\" data-ts=\"1574356923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USO\" target=\"_blank\">USO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521286-crude-oil-climbs-opec-seen-extending-supply-cuts-until-june\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude oil climbs as OPEC seen extending supply cuts until June</a></h4><ul><li>Oil prices are higher following a Reuters report that OPEC and its  allies are <a href=\"https://www.reuters.com/article/us-oil-opec/opec-likely-to-extend-oil-supply-cuts-until-june-sources-idUSKBN1XV17Y\" target=\"_blank\">likely to extend production cuts</a> until mid-2020 when they meet early next month.</li><li>Saudi Arabia wants to focus first on boosting adherence to OPEC's production pact before committing to any more cuts, according to the report.</li><li>Extending <a href=\"https://seekingalpha.com/news/3520905-crude-oil-surges-u-s-supplies-rise-less-expected\" target=\"_blank\">yesterday's strong gains</a>, January WTI crude (NYSEARCA:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>) <font color=\"green\">+1.9%</font> to $58.12/bbl and January Brent (NYSEARCA:<a href='https://seekingalpha.com/symbol/BNO' title='United States Brent Oil Fund, LP'>BNO</a>) <font color=\"green\">+1.8%</font> to $63.56/bbl.</li><li>Oil prices \"<a href=\"https://www.marketwatch.com/story/oil-buoyed-on-talk-of-potential-extension-to-opec-output-cuts-2019-11-21\" target=\"_blank\">got a further boost</a> after Russia signaled it will continue to cooperate with OPEC to restrict output,\" says Raffi Boyadjian, senior investment analyst at XM, but \"without a significant improvement in the global economic outlook, the OPEC cuts will continue to have a limited impact in lifting prices.\"</li><li>The energy group (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color=\"green\">+1.2%</font>) tops the S&amp;P sector leaderboard for the second straight day.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P GSCI Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3x Long Crude Oil ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Trust II - ProShares Ultra Bloomberg Crude Oil'>UCO</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/BNO' title='United States Brent Oil Fund, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity Covington Trust - Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares Trust II - ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/USL' title='United States 12 Month Oil Fund, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/USOU' title='USCF Funds Trust - United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares Trust II - ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3521286\" data-linked=\"Crude oil climbs as OPEC seen extending supply cuts until June\" data-tweet=\"$USO $BNO $XLE - Crude oil climbs as OPEC seen extending supply cuts until June https://seekingalpha.com/news/3521286-crude-oil-climbs-opec-seen-extending-supply-cuts-until-june?source=tweet\" data-url=\"https://seekingalpha.com/news/3521286-crude-oil-climbs-opec-seen-extending-supply-cuts-until-june\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521280\" data-ts=\"1574355577\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521280-village-farms-and-berry-global-among-consumer-gainers-inter-parfums-and-la-z-boy-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Village Farms and Berry Global among Consumer gainers; Inter Parfums and La-Z-Boy among losers</a></h4><ul><li><b>Gainers: </b>Village Farms International (NASDAQ:<a href='https://seekingalpha.com/symbol/VFF' title='Village Farms International, Inc.'>VFF</a>) <font color=\"green\">+10%</font>. Berry Global Group (NYSE:<a href='https://seekingalpha.com/symbol/BERY' title='Berry Global Group, Inc.'>BERY</a>) <font color=\"green\">+10%</font>. XPEL (NASDAQ:<a href='https://seekingalpha.com/symbol/XPEL' title='XPEL, Inc.'>XPEL</a>) <font color=\"green\">+10%</font>. Planet Green (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLAG' title='Planet Green Holdings Corp.'>PLAG</a>) <font color=\"green\">+9%</font>. Arcimoto (NASDAQ:<a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>Inter Parfums (NASDAQ:<a href='https://seekingalpha.com/symbol/IPAR' title='Inter Parfums, Inc.'>IPAR</a>) <font color=\"red\">-13%</font>. La-Z-Boy (NYSE:<a href='https://seekingalpha.com/symbol/LZB' title='La-Z-Boy Incorporated'>LZB</a>) <font color=\"red\">-12%</font>. China Automotive Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a>) <font color=\"red\">-7%</font>. Electrameccanica Vehicles (NASDAQ:<a href='https://seekingalpha.com/symbol/SOLO' title='Electrameccanica Vehicles Corp.'>SOLO</a>) <font color=\"red\">-7%</font>. Natural Health Trends (NASDAQ:<a href='https://seekingalpha.com/symbol/NHTC' title='Natural Health Trends Corp.'>NHTC</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521280\" data-linked=\"Village Farms and Berry Global among Consumer gainers; Inter Parfums and La-Z-Boy among losers\" data-tweet=\"$VFF $BERY $XPEL - Village Farms and Berry Global among Consumer gainers; Inter Parfums and La-Z-Boy among losers https://seekingalpha.com/news/3521280-village-farms-and-berry-global-among-consumer-gainers-inter-parfums-and-la-z-boy-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3521280-village-farms-and-berry-global-among-consumer-gainers-inter-parfums-and-la-z-boy-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521274\" data-ts=\"1574354016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLYC\" target=\"_blank\">GLYC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521274-glycomimetics-sinks-20-after-delaying-trial-top-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GlycoMimetics sinks 20% after delaying trial top-line</a></h4><ul><li>GlycoMimetics (NASDAQ:<a href='https://seekingalpha.com/symbol/GLYC' title='GlycoMimetics, Inc.'>GLYC</a>) plunges 20% after disclosing that it now <a href=\"https://seekingalpha.com/filing/4708118\" target=\"_blank\">expects top-line results</a> from its Phase 3 clinical trial of uproleselan in relapsed/refractory AML in 2021.</li><li>Had previously expected results at<a href=\"https://seekingalpha.com/filing/4708118\" target=\"_blank\"> 2020 end</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521274\" data-linked=\"GlycoMimetics sinks 20% after delaying trial top-line\" data-tweet=\"$GLYC - GlycoMimetics sinks 20% after delaying trial top-line https://seekingalpha.com/news/3521274-glycomimetics-sinks-20-after-delaying-trial-top-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3521274-glycomimetics-sinks-20-after-delaying-trial-top-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521271\" data-ts=\"1574353670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONTX\" target=\"_blank\">ONTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521271-onconova-therapeutics-slides-after-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Onconova Therapeutics slides after share offering</a></h4><ul> <li>Onconova Therapeutics (<a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics, Inc.'>ONTX</a> <font color=\"red\">-42.7%</font>) announces that it priced an offering of 55M shares at $0.20 per share.</li><li>Each share of stock in the offering was sold with a common warrant to purchase one share of common stock at an exercise price of $0.20 per share. The common stock warrants are exercisable immediately and will expire five years from the date of issuance.</li>  <li>Onconova will generate $11M in proceeds from the offering, before deducting fees and expenses.</li><li>The offering is expected to close on or about November 25.</li><li>ONYX is at a 52-week low.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17707811-onconova-therapeutics-inc-announces-11_0-million-public-offering\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3521271\" data-linked=\"Onconova Therapeutics slides after share offering\" data-tweet=\"$ONTX - Onconova Therapeutics slides after share offering https://seekingalpha.com/news/3521271-onconova-therapeutics-slides-after-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3521271-onconova-therapeutics-slides-after-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521270\" data-ts=\"1574353547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521270-facebook-considering-political-ad-changes-dj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook considering political ad changes - DJ</a></h4><ul>    <li>Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color=\"green\">+0.4%</font>) is in discussions with Democratic and Republican ad buyers over <a href=\"https://www.wsj.com/articles/facebook-discussing-potential-changes-to-political-ad-policy-11574352887?mod=breakingnews\" target=\"_blank\">possible changes to its ad policy</a>, Dow Jones reports.</li>    <li>The social network could raise the minimum amount of people able to be targeted by a specific ad, a move that could slow the spread of disinformation, according to the report.</li>    <li>That follows pressure coming from tech rivals who have changed up their policies; Twitter (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color=\"green\">+3.9%</font>) moved to <a href=\"https://seekingalpha.com/news/3511824-twitter-banning-political-ads-updated\" target=\"_blank\">ban political ads entirely</a>, while Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a> <font color=\"red\">-0.5%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet Inc.'>GOOGL</a> <font color=\"red\">-0.6%</font>) staked out a middle ground by heavily <a href=\"https://seekingalpha.com/news/3521072-google-adds-new-limits-political-ad-targeting\" target=\"_blank\">limiting the ability to target</a> political ads.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521270\" data-linked=\"Facebook considering political ad changes - DJ\" data-tweet=\"$FB $GOOG $GOOGL - Facebook considering political ad changes - DJ https://seekingalpha.com/news/3521270-facebook-considering-political-ad-changes-dj?source=tweet\" data-url=\"https://seekingalpha.com/news/3521270-facebook-considering-political-ad-changes-dj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521267\" data-ts=\"1574352466\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRPX\" target=\"_blank\">TRPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521267-therapix-biosciences-to-appeal-nasdaq-de-listing-notice\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Therapix Biosciences to appeal Nasdaq de-listing notice</a></h4><ul><li>Therapix Biosciences (<a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences Ltd.'>TRPX</a> <font color=\"red\">-3.9%</font>) says it <a href=\"https://seekingalpha.com/pr/17706649-therapix-biosciences-announces-receipt-notice-delisting-nasdaq-intention-appeal\" target=\"_blank\">received a de-listing notice</a> from Nasdaq, a decision the company says it will appeal.</li><li>TRPX was notified in May that it no longer complied with the minimum $2.5M stockholders' equity requirement for a continued listing but was granted an extension until Nov. 18 to regain compliance.</li><li>The company says it did not regain compliance because it abandoned its proposed merger with Destiny Bioscience Global Corp.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521267\" data-linked=\"Therapix Biosciences to appeal Nasdaq de-listing notice\" data-tweet=\"$TRPX - Therapix Biosciences to appeal Nasdaq de-listing notice https://seekingalpha.com/news/3521267-therapix-biosciences-to-appeal-nasdaq-de-listing-notice?source=tweet\" data-url=\"https://seekingalpha.com/news/3521267-therapix-biosciences-to-appeal-nasdaq-de-listing-notice\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521263\" data-ts=\"1574352059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521263-baml-names-top-two-food-picks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML names top two food picks</a></h4><ul> <li>Bank of America Merrill Lynch says Mondelez International (NASDAQ:<a href='https://seekingalpha.com/symbol/MDLZ' title='Mondelez International, Inc.'>MDLZ</a>) and Hershey (NYSE:<a href='https://seekingalpha.com/symbol/HSY' title='The Hershey Company'>HSY</a>) are the firm's top picks in the food sector.</li> <li>The BAML analyst team thinks MDLZ and HSY are both skewed more to snacking than other food peers and are in the process of leveraging investments in brands, marketing and capabilities.</li> <li>Mondelez is tagged with a $61 price objective based on 23X the 2020E EPS estimate. The sell-side average PT on Mondelez is <a href=\"https://seekingalpha.com/symbol/MDLZ/ratings/sell-side-ratings\" target=\"_blank\">$60.42</a>.</li> <li>Hershey lands a $165 price objective based on 27X the 2020E EPS of $6.10, a premium to the peer group average of 16X. The average sell-side PT on Hershey is <a href=\"https://seekingalpha.com/symbol/HSY/ratings/sell-side-ratings?s=hsy\" target=\"_blank\">$147.15</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521263\" data-linked=\"BAML names top two food picks\" data-tweet=\"$MDLZ $HSY - BAML names top two food picks https://seekingalpha.com/news/3521263-baml-names-top-two-food-picks?source=tweet\" data-url=\"https://seekingalpha.com/news/3521263-baml-names-top-two-food-picks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521261\" data-ts=\"1574351961\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521261-hepion-pharmaceuticals-leads-healthcare-gainers-glycomimetics-and-optinose-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hepion Pharmaceuticals leads healthcare gainers; GlycoMimetics and OptiNose among losers</a></h4><ul><li><b>Gainers:</b> Hepion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/HEPA' title='Hepion Pharmaceuticals, Inc.'>HEPA</a>) <font color=\"green\">+58%</font>. HEXO (NYSE:<a href='https://seekingalpha.com/symbol/HEXO' title='HEXO Corp.'>HEXO</a>) <font color=\"green\">+18%</font>. Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) <font color=\"green\">+15%</font>. OrganiGram Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OGI' title='OrganiGram Holdings Inc.'>OGI</a>) <font color=\"green\">+14%</font>. Aurora Cannabis (NYSE:<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>) <font color=\"green\">+13%</font>.</li><li><b>Losers:</b> Karuna Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/KRTX' title='Karuna Therapeutics, Inc.'>KRTX</a>) <font color=\"red\">-19%</font>. GlycoMimetics (NASDAQ:<a href='https://seekingalpha.com/symbol/GLYC' title='GlycoMimetics, Inc.'>GLYC</a>) <font color=\"red\">-18%</font>. Cancer Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a>) <font color=\"red\">-15%</font>. Tonix Pharmaceuticals Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"red\">-15%</font>. OptiNose (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTN' title='OptiNose, Inc.'>OPTN</a>) <font color=\"red\">-14%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521261\" data-linked=\"Hepion Pharmaceuticals leads healthcare gainers; GlycoMimetics and OptiNose among losers\" data-tweet=\"$HEPA $HEXO $CGC - Hepion Pharmaceuticals leads healthcare gainers; GlycoMimetics and OptiNose among losers https://seekingalpha.com/news/3521261-hepion-pharmaceuticals-leads-healthcare-gainers-glycomimetics-and-optinose-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3521261-hepion-pharmaceuticals-leads-healthcare-gainers-glycomimetics-and-optinose-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521258\" data-ts=\"1574351184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNY\" target=\"_blank\">SNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521258-sanofi-says-sutimlimab-met-endpoint-in-phase-3-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sanofi says sutimlimab met endpoint in Phase 3 study</a></h4><ul><li>Sanofi (<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a> <font color='green'>+2.3%</font>) moves higher after saying sutimlimab <a href=\"https://seekingalpha.com/pr/17707578-pivotal-data-phase-3-study-sutimlimab-cold-agglutinin-disease-presented-ash-2019-late\" target=\"_blank\">met its primary endpoint</a> for safety and efficacy in a Phase 3 trial for patients with cold agglutinin disease with a history of recent transfusions.</li><li>Sutimlimab is the first investigational complement inhibitor for the treatment of CAD, a rare but severe blood disorder that results in the constant and premature destruction of red blood cells by the body's immune system.</li><li>The primary efficacy outcome was response rate based on a composite of an increase in hemoglobin from baseline or reaching a hemoglobin level at treatment assessment endpoint and the absence of transfusions during weeks 5-26 of the trial.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521258\" data-linked=\"Sanofi says sutimlimab met endpoint in Phase 3 study\" data-tweet=\"$SNY - Sanofi says sutimlimab met endpoint in Phase 3 study https://seekingalpha.com/news/3521258-sanofi-says-sutimlimab-met-endpoint-in-phase-3-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3521258-sanofi-says-sutimlimab-met-endpoint-in-phase-3-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521253\" data-ts=\"1574350617\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSI\" target=\"_blank\">SSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521253-stage-storesplus-23-after-comparable-sales-take-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stage Stores +23% after comparable sales take off</a></h4><ul> <li>Stage Stores (NYSE:<a href='https://seekingalpha.com/symbol/SSI' title='Stage Stores, Inc.'>SSI</a>) soars after reporting comparable sales growth of 17% in <a href=\"https://seekingalpha.com/pr/17706907-stage-stores-reports-17_4-percent-comparable-sales-increase-third-quarter-raises-fiscal-2019\" target=\"_blank\">Q3</a> amid the conversion of more stores to the Gordmans format.</li> <li>Looking ahead, Stage Stores forecasts full-year revenue of $1.64B to $1.67B and adjusted EBITDA of $35M to $40M.</li> <li>Shares of Stage Stores are <font color=\"green\">up 23.32%</font> to $2.75.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521253\" data-linked=\"Stage Stores +23% after comparable sales take off\" data-tweet=\"$SSI - Stage Stores +23% after comparable sales take off https://seekingalpha.com/news/3521253-stage-storesplus-23-after-comparable-sales-take-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3521253-stage-storesplus-23-after-comparable-sales-take-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521250\" data-ts=\"1574350233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521250-natural-gas-inventory-draw-slightly-expected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory draw slightly more than expected</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>-94 Bcf</strong> vs. -89 Bcf consensus, +3 Bcf last week.</li><li>Futures <font color=\"red\">-0.27%</font> to $2.552.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Trust II - ProShares Ultra Bloomberg Natural Gas'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='United States 12 Month Natural Gas Fund, LP'>UNL</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521250\" data-linked=\"Natural gas inventory draw slightly more than expected\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory draw slightly more than expected https://seekingalpha.com/news/3521250-natural-gas-inventory-draw-slightly-expected?source=tweet\" data-url=\"https://seekingalpha.com/news/3521250-natural-gas-inventory-draw-slightly-expected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>82&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521245\" data-ts=\"1574349222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOCU\" target=\"_blank\">DOCU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521245-docusignplus-4-jmp-raises-target-after-conference\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DocuSign +4% as JMP raises target after conference</a></h4><ul><li>JMP Securities raises its DocuSign (NASDAQ:<a href='https://seekingalpha.com/symbol/DOCU' title='DocuSign, Inc.'>DOCU</a>) target from $70 to $75, citing field checks at the user conference that showed that the \"tone of business sounds \u2018exceptional.\u2019\"</li><li>Analyst Patrick Walravens says the company's partnership and channel strategy \"seems to be really resonating,\" and channel productivity could come in \"well above expectations.\"</li><li>The firm raises its estimates for DOCU's Q3 billings, revenue, and earnings.</li><li>JMP reiterates a Market Outperform rating. DOCU has a Bullish average <a href=\"https://seekingalpha.com/symbol/DOCU/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>DOCU shares are u<font color=\"green\">p 4.1%</font> to $70.64.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521245\" data-linked=\"DocuSign +4% as JMP raises target after conference\" data-tweet=\"$DOCU - DocuSign +4% as JMP raises target after conference https://seekingalpha.com/news/3521245-docusignplus-4-jmp-raises-target-after-conference?source=tweet\" data-url=\"https://seekingalpha.com/news/3521245-docusignplus-4-jmp-raises-target-after-conference\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521242\" data-ts=\"1574348916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521242-exxon-to-step-up-asset-sales-sweeping-25b-plan-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exxon to step up asset sales with sweeping $25B plan - Reuters</a></h4><ul><li>Exxon Mobil (<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color='green'>+1.6%</font>) is accelerating its biggest asset sale in decades with <a href=\"https://www.reuters.com/article/us-exxon-mobil-m-a-exclusive/exclusive-exxon-steps-up-assets-sales-with-sweeping-25-billion-plan-idUSKBN1XV1Q9\" target=\"_blank\">plans to divest  as much as $25B</a> of oil and gas fields in Europe, Asia and Africa, Reuters reports.</li><li>XOM has drawn up an extensive list of assets from at  least 11 countries it wants to sell that would easily exceed its current  $15B disposal target for 2021, according to the report.</li><li>The expanded plan would see XOM effectively exiting its upstream oil  and gas operations in Europe, selling out of the U.K. North Sea, Germany and  Romania, and a significant reduction of operations in Southeast Asia with the sale of its assets in Indonesia and Malaysia.</li><li>XOM has been facing growing pressure from investors to free up cash as it plans to increase spending for new  developments in Guyana, Mozambique, Papua New Guinea and the U.S.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521242\" data-linked=\"Exxon to step up asset sales with sweeping $25B plan - Reuters\" data-tweet=\"$XOM - Exxon to step up asset sales with sweeping $25B plan - Reuters https://seekingalpha.com/news/3521242-exxon-to-step-up-asset-sales-sweeping-25b-plan-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3521242-exxon-to-step-up-asset-sales-sweeping-25b-plan-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>74&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521233\" data-ts=\"1574347978\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPAR\" target=\"_blank\">IPAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521233-inter-parfumsminus-6-after-guidance-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inter Parfums -6% after guidance disappoints</a></h4><ul> <li>Inter Parfums (NASDAQ:<a href='https://seekingalpha.com/symbol/IPAR' title='Inter Parfums, Inc.'>IPAR</a>) sinks after setting initial FY20 revenue guidance at ~$742M vs. $765M consensus.</li> <li>IPAR's outlook: \"Our initial 2020 net sales guidance implies a 4.2% year-over-year increase based upon our 2019 net sales guidance of $712M. In constant dollars, the increase in net sales would approximate 4.9%, with the continued strength of the dollar slightly understating the growth of our business. Since over 45% of net sales of our European operations are denominated in U.S. dollars, while almost all associated costs are incurred in euro, the strong U.S. dollar has a favorable impact on gross margin. Thus, we look for 2020 net income per diluted share to increase 5.3% as compared to $1.90, our 2019 estimate. As the year unfolds and we have greater visibility, we will update our 2020 guidance as appropriate.\"</li> <li>Shares of Inter Parfums are <font color=\"red\">down 5.52%</font> to $72.94 vs. the 52-week trading range of $57.37 to $81.40.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521233\" data-linked=\"Inter Parfums -6% after guidance disappoints\" data-tweet=\"$IPAR - Inter Parfums -6% after guidance disappoints https://seekingalpha.com/news/3521233-inter-parfumsminus-6-after-guidance-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3521233-inter-parfumsminus-6-after-guidance-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521221\" data-ts=\"1574346773\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYEKF\" target=\"_blank\">TYEKF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521221-thyssenkrupp-plans-to-scrap-dividend-losses-mount\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thyssenkrupp plans to scrap dividend as losses mount</a></h4><ul><li>Thyssenkrupp (<a href='https://seekingalpha.com/symbol/TYEKF' title='thyssenkrupp AG'>OTCPK:TYEKF</a>) <font color=\"red\">-13.6%</font> in Frankfurt after moving to <a href=\"https://finance.yahoo.com/news/thyssenkrupp-set-suspend-dividend-055858166.html\" target=\"_blank\">suspend dividend payments</a> and warning of widening losses.</li><li>\"<a href=\"https://www.wsj.com/articles/thyssenkrupp-losses-widen-as-new-ceo-pushes-unit-sale-11574327800\" target=\"_blank\">We are leaving no stone unturned</a>,\" new CEO Martina Merz says, as the company reported its net loss in the fiscal year ending Sept. 30 had ballooned to \u20ac304M ($337M) from \u20ac62M in the previous year.</li><li>Merz says the company will cut more than 600 jobs at its struggling automotive plant division and slash the number of workers at its headquarters in Essen, Germany, by half.</li><li>Thyssenkrupp says its earnings performance for FY 2019-20 is uncertain but expects adjusted EBIT near this year's level of \u20ac802M ($890M), and forecasts net losses will be significantly worse in this fiscal year due to restructuring costs.</li><li>The company expects binding offers for its elevator unit in the next year and already has received indicative offers from strategic and financial investors, and says preparations for a possible IPO will be completed by the end of this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521221\" data-linked=\"Thyssenkrupp plans to scrap dividend as losses mount\" data-tweet=\"$TYEKF $TKAMY - Thyssenkrupp plans to scrap dividend as losses mount https://seekingalpha.com/news/3521221-thyssenkrupp-plans-to-scrap-dividend-losses-mount?source=tweet\" data-url=\"https://seekingalpha.com/news/3521221-thyssenkrupp-plans-to-scrap-dividend-losses-mount\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521218\" data-ts=\"1574346565\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPTH\" target=\"_blank\">BPTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521218-fda-clears-bio-paths-ind-for-bp1002\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA clears Bio-Path&#39;s IND for BP1002</a></h4><ul><li>The FDA has <a href=\"https://seekingalpha.com/pr/17707153-bio-path-holdings-announces-clearance-investigational-new-drug-application-bp1002\" target=\"_blank\">reviewed</a> and cleared Bio-Path Holdings' (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) IND application for BP1002 (liposomal Bcl-2), the Company\u2019s second drug candidate.</li><li>An initial Phase 1 clinical trial will evaluate the ability of BP1002 to treat refractory/relapsed lymphoma and chronic lymphocytic leukemia patients.</li><li>Shares are up <font color=\"green\">15%</font> premarket.</li>         </ul><div class=\"tiny-share-widget\" data-id=\"3521218\" data-linked=\"FDA clears Bio-Path&#39;s IND for BP1002\" data-tweet=\"$BPTH - FDA clears Bio-Path&#39;s IND for BP1002 https://seekingalpha.com/news/3521218-fda-clears-bio-paths-ind-for-bp1002?source=tweet\" data-url=\"https://seekingalpha.com/news/3521218-fda-clears-bio-paths-ind-for-bp1002\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521215\" data-ts=\"1574346301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521215-amtd-schw-cgc-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMTD, SCHW, CGC among premarket gainers</a></h4><ul><li>Hepion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/HEPA' title='Hepion Pharmaceuticals, Inc.'>HEPA</a>) <font color=\"green\">+75%</font> after <a href=\"https://seekingalpha.com/news/3521173-hepion-pharma-soars-treatment-prevents-liver-cirrhosis-test\" target=\"_blank\">CRV431 prevents cirrhosis</a> in experimental model of severe liver disease.</li><li>TD Ameritrade Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a>) <font color=\"green\">+24%</font> on <a href=\"https://seekingalpha.com/news/3521105-td-ameritrade-soars-schwab-buyout-report\" target=\"_blank\">Schwab buyout</a> report.</li><li>Stage Stores (NYSE:<a href='https://seekingalpha.com/symbol/SSI' title='Stage Stores, Inc.'>SSI</a>) <font color=\"green\">+22%</font> on <a href=\"https://seekingalpha.com/news/3521119-stage-stores-reports-q3-results\" target=\"_blank\">Q3 earnings</a>.</li><li>Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"green\">+22%</font> after <a href=\"https://seekingalpha.com/pr/17707153-bio-path-holdings-announces-clearance-investigational-new-drug-application-bp1002\" target=\"_blank\">FDA clears</a> IND for BP1002.</li><li>Anaplan (NYSE:<a href='https://seekingalpha.com/symbol/PLAN' title='Anaplan, Inc.'>PLAN</a>) <font color=\"green\">+14%</font> on <a href=\"https://seekingalpha.com/news/3521146-anaplan-eps-beats-0_05-beats-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li>The Charles Schwab (NYSE:<a href='https://seekingalpha.com/symbol/SCHW' title='The Charles Schwab Corporation'>SCHW</a>) <font color=\"green\">+10%</font> on <a href=\"https://seekingalpha.com/news/3521105-td-ameritrade-soars-schwab-buyout-report\" target=\"_blank\">Schwab buyout</a> report.</li><li>Celyad SA (NASDAQ:<a href='https://seekingalpha.com/symbol/CYAD' title='Celyad SA'>CYAD</a>) <font color=\"green\">+10%</font>.</li><li>Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) <font color=\"green\">+8%</font> following House passage of a <a href=\"https://seekingalpha.com/news/3521212-pot-names-continue-bounce\" target=\"_blank\">pot decriminalization bill</a>.</li><li>Nuance Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/NUAN' title='Nuance Communications, Inc.'>NUAN</a>) <font color=\"green\">+8%</font> on <a href=\"https://seekingalpha.com/news/3520973-nuance-communications-eps-beats-0_06-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Westwater Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/WWR' title='Westwater Resources, Inc.'>WWR</a>) <font color=\"green\">+7% </font>on <a href=\"https://seekingalpha.com/pr/17707098-westwater-resources-engages-dorfner-anzaplan-accelerate-product-development-design-graphite\" target=\"_blank\">engaging</a> Dorfner Anzaplan to accelerate product development and design for Graphite pilot program.</li><li>SunPower (NASDAQ:<a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a>) <font color=\"green\">+6%</font>.</li><li>Star Bulk Carriers (NASDAQ:<a href='https://seekingalpha.com/symbol/SBLK' title='Star Bulk Carriers Corp.'>SBLK</a>) <font color=\"green\">+6%</font>. on <a href=\"https://seekingalpha.com/news/3521047-star-bulk-carriers-eps-misses-0_03-beats-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li>Tilray (NASDAQ:<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a>) <font color=\"green\">+6%</font> following House passage of a <a href=\"https://seekingalpha.com/news/3521212-pot-names-continue-bounce\" target=\"_blank\">pot decriminalization bill</a>.</li><li>Copart (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRT' title='Copart, Inc.'>CPRT</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3521064-copart-eps-beats-0_06-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Cronos Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group Inc.'>CRON</a>) <font color=\"green\">+6%</font> following House passage of a <a href=\"https://seekingalpha.com/news/3521212-pot-names-continue-bounce\" target=\"_blank\">pot decriminalization bill</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521215\" data-linked=\"AMTD, SCHW, CGC among premarket gainers\" data-tweet=\"$HEPA $AMTD $SSI - AMTD, SCHW, CGC among premarket gainers https://seekingalpha.com/news/3521215-amtd-schw-cgc-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3521215-amtd-schw-cgc-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521213\" data-ts=\"1574346084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521213-crispr-therapeutics-prices-public-offering-64_50-per-share-shares-down-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CRISPR Therapeutics prices public offering at $64.50 per share; shares down ~3%</a></h4><ul><li>CRISPR Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics AG'>CRSP</a>) dips <font color=\"red\">3.13%</font> in pre-market, as the company <a href=\"https://seekingalpha.com/pr/17706717-crispr-therapeutics-announces-pricing-public-offering-common-shares\" target=\"_blank\">prices</a> its 4.25M shares public offering at $64.50/share</li><li>The company expects gross proceeds of ~$274.1M and the offering is expected to close by November 25, 2019</li><li>Previously: <a href=\"https://seekingalpha.com/news/3520657-crispr-therapeutics-5-percent-hours-equity-offering\" target=\"_blank\">CRISPR Therapeutics down 5% after hours on equity offering</a> (Nov. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3521213\" data-linked=\"CRISPR Therapeutics prices public offering at $64.50 per share; shares down ~3%\" data-tweet=\"$CRSP - CRISPR Therapeutics prices public offering at $64.50 per share; shares down ~3% https://seekingalpha.com/news/3521213-crispr-therapeutics-prices-public-offering-64_50-per-share-shares-down-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3521213-crispr-therapeutics-prices-public-offering-64_50-per-share-shares-down-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521212\" data-ts=\"1574345932\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGC\" target=\"_blank\">CGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521212-pot-names-continue-to-bounce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pot names continue to bounce</a></h4><ul><li>The roughed-up sector is looking good for a 2nd day following House passage of a pot decriminalization bill.</li><li>Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) <font color=\"green\">+9.5%</font>, Cronos Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group Inc.'>CRON</a>) <font color=\"green\">+5.4%</font>, Aurora Cannabis (NYSE:<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>) <font color=\"green\">+5.3%</font>, Tilray (NASDAQ:<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a>) <font color=\"green\">+6%</font>.</li><li>The ETFMG Alternative Harvest ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/MJ' title='ETFMG Alternative Harvest ETF'>MJ</a>) <font color=\"green\">+3.6%</font>.</li><li>In fresh news, Canopy Growth <a href=\"https://seekingalpha.com/pr/17707346-canopy-growth-comments-class-securities-litigation\" target=\"_blank\">puts out a press release</a> saying it's aware of yet-to-be-certified securities class-action suits having been filed in the U.S., and intends a vigorous defense.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521212\" data-linked=\"Pot names continue to bounce\" data-tweet=\"$CGC $CRON $ACB - Pot names continue to bounce https://seekingalpha.com/news/3521212-pot-names-continue-to-bounce?source=tweet\" data-url=\"https://seekingalpha.com/news/3521212-pot-names-continue-to-bounce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521206\" data-ts=\"1574345476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521206-bj-bzun-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BJ, BZUN among premarket losers</a></h4><ul><li>OptiNose (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTN' title='OptiNose, Inc.'>OPTN</a>) <font color=\"red\">-15%</font> on <a href=\"https://seekingalpha.com/news/3521080-optinose-minus-9_7-percent-report-offering-14_6-percent-discount\" target=\"_blank\">report of offering</a> at 14.6% discount.</li><li>BJ's Wholesale Club Holdings (NYSE:<a href='https://seekingalpha.com/symbol/BJ' title='BJ&#39;s Wholesale Club Holdings, Inc.'>BJ</a>) <font color=\"red\">-13%</font> on <a href=\"https://seekingalpha.com/news/3521120-bj-s-wholesale-club-eps-beats-0_01-misses-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li>Baozun (NASDAQ:<a href='https://seekingalpha.com/symbol/BZUN' title='Baozun Inc.'>BZUN</a>) <font color=\"red\">-10%</font> on <a href=\"https://seekingalpha.com/news/3521087-baozun-eps-misses-0_01-misses-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li>Viveve Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a>) <font color=\"red\">-9%</font>.</li><li>Karuna Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/KRTX' title='Karuna Therapeutics, Inc.'>KRTX</a>) <font color=\"red\">-9%</font> on <a href=\"https://seekingalpha.com/pr/17706682-karuna-therapeutics-announces-pricing-250-million-public-offering-common-stock\" target=\"_blank\">pricing</a> stock offering.</li><li>Diamond S Shipping (NYSE:<a href='https://seekingalpha.com/symbol/DSSI' title='Diamond S Shipping Inc.'>DSSI</a>) <font color=\"red\">-8%</font> on <a href=\"https://seekingalpha.com/pr/17706522-diamond-s-shipping-inc-announces-launch-public-offering-selling-shareholders\" target=\"_blank\">launching</a> public offering by selling shareholders.</li><li>Cancer Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a>) <font color=\"red\">-8%</font>.</li><li>E*TRADE Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a>) <font color=\"red\">-6%</font> as hopes of a <a href=\"https://seekingalpha.com/news/3521167-interactive-brokers-gains-e-trade-falls-schwab-ameritrade-talk\" target=\"_blank\">AMTD-ETFC tie-up</a> are dashed.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521206\" data-linked=\"BJ, BZUN among premarket losers\" data-tweet=\"$OPTN $BJ $BZUN - BJ, BZUN among premarket losers https://seekingalpha.com/news/3521206-bj-bzun-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3521206-bj-bzun-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521205\" data-ts=\"1574345423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENLV\" target=\"_blank\">ENLV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521205-enlivex-therapeutics-pulls-proposed-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enlivex Therapeutics pulls proposed offering</a></h4><ul><li>Enlivex Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ENLV' title='Enlivex Therapeutics Ltd.'>ENLV</a>) <font color=\"green\">+2%</font> pre-market after <a href=\"https://www.streetinsider.com/Corporate+News/Enlivex+Therapeutics+Ltd.+%28ENLV%29+Announces+Withdrawal+of+Proposed+Offering+of+Ordinary+Shares/16163201.html\" target=\"_blank\">withdrawing</a> its previously announced public stock offering, citing \"market conditions.\"</li><li>ENLV says it remains well capitalized with $13.5M in cash and cash equivalents as of Sept. 30, which the company believes will be sufficient to fund its current  operations through the beginning of Q2 2021.</li><li>The company <a href=\"https://seekingalpha.com/pr/17706469-enlivex-therapeutics-ltd-announces-proposed-offering-ordinary-shares\" target=\"_blank\">had said</a> it would use proceeds from the offering for  clinical, regulatory, manufacturing and research and development  activities, potential acquisitions and in-licensing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521205\" data-linked=\"Enlivex Therapeutics pulls proposed offering\" data-tweet=\"$ENLV - Enlivex Therapeutics pulls proposed offering https://seekingalpha.com/news/3521205-enlivex-therapeutics-pulls-proposed-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3521205-enlivex-therapeutics-pulls-proposed-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521200\" data-ts=\"1574344950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNY\" target=\"_blank\">SNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521200-sanofi-weighing-options-for-consumer-healthcare-unit-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sanofi weighing options for consumer healthcare unit - Reuters</a></h4><ul><li>Sanofi (NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>) <font color=\"green\">+1.6%</font> pre-market following a Reuters report that it is <a href=\"https://www.reuters.com/article/us-sanofi-strategy/sanofi-weighing-options-for-consumer-healthcare-unit-sources-idUSKBN1XV1B8\" target=\"_blank\">considering a joint venture, IPO or outright sale</a> of its consumer healthcare unit.</li><li>A JV with a large peers would allow SNY to benefit from  cost cuts and later reap a higher valuation in a possible eventual sale or IPO of the unit, according to the report, which says an IPO could be worth  ~$30B.</li><li>Analysts have speculated over a possible divestment or  spinoff of the consumer healthcare business, whose revenue rose 3%  at constant exchange rates last year to \u20ac4.7B ($5.21B), arguing proceeds would enable SNY to invest more in  internal research.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521200\" data-linked=\"Sanofi weighing options for consumer healthcare unit - Reuters\" data-tweet=\"$SNY - Sanofi weighing options for consumer healthcare unit - Reuters https://seekingalpha.com/news/3521200-sanofi-weighing-options-for-consumer-healthcare-unit-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3521200-sanofi-weighing-options-for-consumer-healthcare-unit-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521181\" data-ts=\"1574343118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DARE\" target=\"_blank\">DARE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521181-dar-bioplus-22-premarket-on-completing-microchips-bio-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Daré Bio +22% premarket on completing Microchips Bio acquisition</a></h4><ul><li>Daré Bioscience (NASDAQ:<a href='https://seekingalpha.com/symbol/DARE' title='Daré Bioscience, Inc.'>DARE</a>) <a href=\"https://seekingalpha.com/pr/17707063-dare-bioscience-closes-previously-announced-acquisition-microchips-biotech-first-class\" target=\"_blank\">closes</a> its acquisition of privately-held Microchips Biotech, Inc. a developer of an innovative, wireless, user-controlled drug delivery technology with potential utility across multiple therapeutic areas, including contraception.</li>    <li>Daré will issue an aggregate of ~3M common shares in exchange for the cash and equivalents of Microchips at closing.</li><li>Cheryl Blanchard, Ph.D., the former president and CEO of Microchips, joined Daré\u2019s board of directors upon the closing of the merger.</li><li>Shares are up <font color=\"green\">22%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3517586-dare-bio-11-percent-takeover-implant-technology-developer\" target=\"_blank\">Daré Bio up 11% on takeover of implant technology developer</a> (Nov. 11)</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3521181\" data-linked=\"Daré Bio +22% premarket on completing Microchips Bio acquisition\" data-tweet=\"$DARE - Daré Bio +22% premarket on completing Microchips Bio acquisition https://seekingalpha.com/news/3521181-dar-bioplus-22-premarket-on-completing-microchips-bio-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3521181-dar-bioplus-22-premarket-on-completing-microchips-bio-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521175\" data-ts=\"1574342662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BERY\" target=\"_blank\">BERY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521175-berry-plastics-reaffirms-fy2020-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Berry Plastics reaffirms FY2020 outlook</a></h4><ul><li>Berry Plastics (NYSE:<a href='https://seekingalpha.com/symbol/BERY' title='Berry Global Group, Inc.'>BERY</a>) reports top line growth of 47% in <a href=\"https://seekingalpha.com/pr/17707048-berry-global-group-inc-reports-fourth-quarter-fiscal-year-2019-results-reaffirms-fiscal-year\" sasource=\"qp_sum_news_4\" target=\"_blank\">Q4</a>.</li><li>Consumer Packaging net sales was $1.82B.</li><li>Health, Hygiene, &amp; Specialties net sales down 16.2% to $570M.</li><li>Engineered Materials net sales decreased 6.7% to $628M.</li><li>Gross margin rate down 20 bps to 16.8%.</li><li>SG&amp;A expense rate fell 100 bps to 6.6%.</li><li>Adjusted operating margin rate slipped 80 bps to 9.5%.</li><li>Operating EBITDA up 43.6% to $497M.</li><li><strong>FY2020 Guidance</strong>: Cash flow from operation: $1.4B; Adjusted free cash flow: $800M; Capex: $600M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3521151-berry-plastics-eps-beats-0_17-misses-revenue\" target=\"_blank\">Berry Plastics EPS beats by $0.17, misses on revenue</a> (Nov. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3521175\" data-linked=\"Berry Plastics reaffirms FY2020 outlook\" data-tweet=\"$BERY - Berry Plastics reaffirms FY2020 outlook https://seekingalpha.com/news/3521175-berry-plastics-reaffirms-fy2020-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3521175-berry-plastics-reaffirms-fy2020-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521174\" data-ts=\"1574342429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGNX\" target=\"_blank\">MGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521174-macrogenicsminus-6_1-premarket-morgan-stanley-turns-bear\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MacroGenics -6.1% premarket as Morgan Stanley turns bear</a></h4><ul><li>MacroGenics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGNX' title='MacroGenics, Inc.'>MGNX</a>)<font color=\"red\"> sinks 6.1% </font>in premarket trading after Morgan Stanley analyst David Lebowitz cuts his rating to underweight from equal-weight.</li><li>Sees limited sales opportunity for MGNX's cancer drug Margetuximab even if it gets FDA approval after a second interim overall survival analysis.</li><li>He's concerned that recent interim analysis suggests the drug will fall short on the final overall analysis.</li><li>Quant rating is<a href=\"https://seekingalpha.com/symbol/MGNX/ratings/quant-ratings\" target=\"_blank\"> Very Bearish</a>; before this action, the Sell-Side average rating was <a href=\"https://seekingalpha.com/symbol/MGNX/ratings/sell-side-ratings\" target=\"_blank\">Bullish </a>(7 Very Bullish, 3 Bullish, 2 Neutral).</li></ul><div class=\"tiny-share-widget\" data-id=\"3521174\" data-linked=\"MacroGenics -6.1% premarket as Morgan Stanley turns bear\" data-tweet=\"$MGNX - MacroGenics -6.1% premarket as Morgan Stanley turns bear https://seekingalpha.com/news/3521174-macrogenicsminus-6_1-premarket-morgan-stanley-turns-bear?source=tweet\" data-url=\"https://seekingalpha.com/news/3521174-macrogenicsminus-6_1-premarket-morgan-stanley-turns-bear\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521173\" data-ts=\"1574342427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEPA\" target=\"_blank\">HEPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521173-hepion-pharma-soars-after-treatment-prevents-liver-cirrhosis-in-test\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hepion Pharma soars after treatment prevents liver cirrhosis in test</a></h4><ul><li>Hepion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/HEPA' title='Hepion Pharmaceuticals, Inc.'>HEPA</a>) <font color=\"green\">+57.4%</font> pre-market after saying its CRV431 anti-fibrotic agent <a href=\"https://seekingalpha.com/pr/17706504-hepion-pharmaceuticals-crv431-prevents-cirrhosis-experimental-model-severe-liver-disease\" target=\"_blank\">prevented the development of liver cirrhosis</a> in a highly aggressive, pre-clinical model of liver disease.</li><li>In the study, rats were administered thioacetamide for  nine weeks to induce liver injury and fibrosis, in combination with  either CRV431 or vehicle control for the entire study period.</li><li>HEPA says the study's findings are an important pre-clinical milestone for CRV431 \"because  thioacetamide administration to rats is recognized to produce among the  most severe liver disease of all experimental models.\"</li><li>\"Every fibrosis study that we have conducted thus far, whether in animals  or in human liver slices, has demonstrated CRV431's strong  anti-fibrotic activity, contributing to a body of preclinical efficacy  data that complements our ongoing human clinical trials,\" the company says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521173\" data-linked=\"Hepion Pharma soars after treatment prevents liver cirrhosis in test\" data-tweet=\"$HEPA - Hepion Pharma soars after treatment prevents liver cirrhosis in test https://seekingalpha.com/news/3521173-hepion-pharma-soars-after-treatment-prevents-liver-cirrhosis-in-test?source=tweet\" data-url=\"https://seekingalpha.com/news/3521173-hepion-pharma-soars-after-treatment-prevents-liver-cirrhosis-in-test\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521172\" data-ts=\"1574342381\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LZB\" target=\"_blank\">LZB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521172-la-z-boyminus-10-after-earnings-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">La-Z-Boy -10% after earnings disappoint</a></h4><ul> <li>Shares of La-Z-Boy (NYSE:<a href='https://seekingalpha.com/symbol/LZB' title='La-Z-Boy Incorporated'>LZB</a>) slump after the furniture company misses on both lines of its Q3 report.</li> <li>Written same-store sales for the La-Z-Boy Furniture Galleries network were up 3.5% during the quarter, while same-store sales for the company-owned retail segment rose 5.0%.</li> <li>Operating margin improved 20 bps to 7.5% of sales.</li> <li>La-Z-Boy boosted its dividend payout rate by 8%.</li> <li>LZB <font color=\"red\">-10.17%</font> premarket to $32.50.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3521004-la-z-boy-eps-misses-0_03-misses-revenue\" target=\"_blank\">La-Z-Boy EPS misses by $0.03, misses on revenue</a> (Nov. 20)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521172\" data-linked=\"La-Z-Boy -10% after earnings disappoint\" data-tweet=\"$LZB - La-Z-Boy -10% after earnings disappoint https://seekingalpha.com/news/3521172-la-z-boyminus-10-after-earnings-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3521172-la-z-boyminus-10-after-earnings-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521171\" data-ts=\"1574342362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521171-ubs-turns-bearish-on-semi-equipment-names\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS turns bearish on semi equipment names</a></h4><ul><li>UBS cuts Applied Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a>) and Lam Research (NASDAQ:<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a>) from Neutral to Sell. Peer KLA (NASDAQ:<a href='https://seekingalpha.com/symbol/KLAC' title='KLA Corporation'>KLAC</a>) gets a two-notch downgrade from Buy to Sell.</li><li>Analyst Timothy Arcuri cites a \"peaking\" run-rate for some semi stocks.</li><li>Arcuri: \"Foundry/logic is the most extended and vulnerable to these run-rate headwinds and memory WFE remains very healthy, but we nonetheless see downside for the entire group.\"</li><li>Targets: AMAT, $48 (20% downside); Lam, $240 (12% downside); KLA, $140 (19% downside).</li><li><a href=\"https://seekingalpha.com/symbol/AMAT/ratings/sell-side-ratings\" target=\"_blank\">AMAT</a>, <a href=\"https://seekingalpha.com/symbol/LRCX/ratings/sell-side-ratings?s=lrcx\" target=\"_blank\">Lam</a>, and <a href=\"https://seekingalpha.com/symbol/KLAC/ratings/sell-side-ratings?s=klac\" target=\"_blank\">KLA</a> have Bullish average Sell Side ratings.</li><li>Applied Materials shares are <font color=\"red\">down 2.4%</font> pre-market to $58.23. Lam is <font color=\"red\">down 2.9%</font> to $266.20, and KLA <font color=\"red\">falls 3%</font> to $168.50.</li><li>Post updated with more details from the note.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521171\" data-linked=\"UBS turns bearish on semi equipment names\" data-tweet=\"$AMAT $LRCX $KLAC - UBS turns bearish on semi equipment names https://seekingalpha.com/news/3521171-ubs-turns-bearish-on-semi-equipment-names?source=tweet\" data-url=\"https://seekingalpha.com/news/3521171-ubs-turns-bearish-on-semi-equipment-names\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521170\" data-ts=\"1574342262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVIV\" target=\"_blank\">NVIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521170-invivo-down-45-premarket-on-pricing-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InVivo down 45% premarket on pricing stock offering</a></h4><ul> <li>InVivo Therapeutics Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp.'>NVIV</a>) has <a href=\"https://seekingalpha.com/pr/17707077-invivo-therapeutics-announces-pricing-public-offering-common-stock\" target=\"_blank\">priced</a> its public offering of 7M common shares at $0.12 per share, for expected gross proceeds of $840,000.</li><li>Closing date is November 22.</li><li>Shares are down <font color=\"red\">45%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3520176-invivo-launches-equity-offering-shares-17-percent\" target=\"_blank\">InVivo launches equity offering; shares down 17%</a> (Nov. 18)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521170\" data-linked=\"InVivo down 45% premarket on pricing stock offering\" data-tweet=\"$NVIV - InVivo down 45% premarket on pricing stock offering https://seekingalpha.com/news/3521170-invivo-down-45-premarket-on-pricing-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3521170-invivo-down-45-premarket-on-pricing-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521168\" data-ts=\"1574341937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOC\" target=\"_blank\">BIOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521168-biocept-launches-new-liquid-biopsy-test\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biocept launches new liquid biopsy test</a></h4><ul><li>Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) announces the commercial availability of its Target Selector pan-TRK assay for the detection of TRK proteins.</li><li>The company says a simple blood sample can help inform physicians on the potential presence of NTRK fusions, which are actionable biomarkers that can be used to qualify patients for treatment with TRK inhibitor therapies.</li><li>Biocept now offers 20 commercially available liquid biopsy assays, including two tumor-specific next generation sequencing panels that cover the most actionable genomic alterations for solid tumors.</li><li>Shares of BIOC are <font color=\"green\">up 4.85%</font> premarket.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17707199-biocept-announces-launch-liquid-biopsy-test-detect-trk-biomarkers-blood-patients-diagnosed\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3521168\" data-linked=\"Biocept launches new liquid biopsy test\" data-tweet=\"$BIOC - Biocept launches new liquid biopsy test https://seekingalpha.com/news/3521168-biocept-launches-new-liquid-biopsy-test?source=tweet\" data-url=\"https://seekingalpha.com/news/3521168-biocept-launches-new-liquid-biopsy-test\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521167\" data-ts=\"1574341512\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETFC\" target=\"_blank\">ETFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521167-interactive-brokers-gains-e-trade-falls-on-schwab-ameritrade-talk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interactive Brokers gains, E*TRADE falls on Schwab-Ameritrade talk</a></h4><ul><li>Interactive Brokers (NASDAQ:<a href='https://seekingalpha.com/symbol/IBKR' title='Interactive Brokers Group, Inc.'>IBKR</a>)<font color=\"green\"> gains 1.1%</font> in premarket trading following reports that Charles Schwab (NYSE:<a href='https://seekingalpha.com/symbol/SCHW' title='The Charles Schwab Corporation'>SCHW</a>)<a href=\"https://seekingalpha.com/news/3521105-td-ameritrade-soars-schwab-buyout-report\" target=\"_blank\"> is in talks </a>to buy TD Ameritrade (NASDAQ:<a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a>) for $26B.</li><li>Rival online broker E*TRADE (NASDAQ:<a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a>)<font color=\"red\"> falls 4.7%</font>, as hopes of a AMTD-ETFC tie-up are dashed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521167\" data-linked=\"Interactive Brokers gains, E*TRADE falls on Schwab-Ameritrade talk\" data-tweet=\"$ETFC $SCHW $AMTD - Interactive Brokers gains, E*TRADE falls on Schwab-Ameritrade talk https://seekingalpha.com/news/3521167-interactive-brokers-gains-e-trade-falls-on-schwab-ameritrade-talk?source=tweet\" data-url=\"https://seekingalpha.com/news/3521167-interactive-brokers-gains-e-trade-falls-on-schwab-ameritrade-talk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521155\" data-ts=\"1574340717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IOVA\" target=\"_blank\">IOVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521155-iovanceplus-4_5-after-new-data-on-lifileucel-melanoma-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iovance +4.5% after new data on lifileucel melanoma study</a></h4><ul><li>Iovance Biotherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/IOVA' title='Iovance Biotherapeutics, Inc.'>IOVA</a>)<font color=\"green\"> jumps 4.5%</font> in premarket trading after <a href=\"https://seekingalpha.com/pr/17706946-iovance-biotherapeutics-announces-results-subgroup-analysis-patients-lifileucel-metastatic\" target=\"_blank\">reporting 41% objective response</a> rate in 42 patients in Cohort 2 of Phase 2 lifileucel metastatic melanoma study C-144-01 in patients who were primary refractory to prior anti-PD-1/L1 therapy.</li><li>Median duration of response wasn't reached as assessed by the investigator at 12 months of study follow-up for the primary refractory group.</li><li>An abstract with details of the analysis was accepted as a late-breaking poster at the 16th International Congress of the Society for Melanoma Research being held Nov. 20-22 in Salt Lake City.</li><li>71% of responders who are primary refractory to anti PD-1/L1 therapy remain on study.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3517120-iovance-12-percent-premarket-positive-lifileucel-data\" target=\"_blank\">Iovance up 12% premarket on positive lifileucel data</a> (Nov. 8)</li><li></li></ul><div class=\"tiny-share-widget\" data-id=\"3521155\" data-linked=\"Iovance +4.5% after new data on lifileucel melanoma study\" data-tweet=\"$IOVA - Iovance +4.5% after new data on lifileucel melanoma study https://seekingalpha.com/news/3521155-iovanceplus-4_5-after-new-data-on-lifileucel-melanoma-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3521155-iovanceplus-4_5-after-new-data-on-lifileucel-melanoma-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521153\" data-ts=\"1574340523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLAN\" target=\"_blank\">PLAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521153-anaplanplus-12-after-beat-and-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anaplan +12% after beat-and-raise</a></h4><ul><li>Anaplan (NYSE:<a href='https://seekingalpha.com/symbol/PLAN' title='Anaplan, Inc.'>PLAN</a>) <font color=\"green\">gains 11.9%</font> after <a href=\"https://seekingalpha.com/news/3521146-anaplan-eps-beats-0_05-beats-revenue\" target=\"_blank\">reporting</a> upside Q3 results.</li><li>Subscription revenue was up 46% Y/Y to $79.7M. Professional Services grew 27% to $9.72M.</li><li>Adjusted operating margin was -9.9% compared to -29.5% in last year's quarter.</li><li>Negative FCF was up 15% Y/Y to $19.9M.</li><li>Outlook: For Q4, PLAN sees revenue of $96.5-97.5M and an operating margin between -14 and -15%. FY20 sees $346-347M (was: $339-343M) and operating margin of -17% to -18% (was: -19.5% to -20.5%).</li><li>Earnings call starts at 8:30 AM ET with a webcast <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.anaplan.com&amp;esheet=52133236&amp;newsitemid=20191121005463&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.anaplan.com&amp;index=6&amp;md5=c4745e49ad4b5276653a8f826b2ad07d\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17707037-anaplan-announces-third-quarter-fiscal-year-2020-financial-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521153\" data-linked=\"Anaplan +12% after beat-and-raise\" data-tweet=\"$PLAN - Anaplan +12% after beat-and-raise https://seekingalpha.com/news/3521153-anaplanplus-12-after-beat-and-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3521153-anaplanplus-12-after-beat-and-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521152\" data-ts=\"1574340482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHIO\" target=\"_blank\">PHIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521152-phio-pharmaplus-51-premarket-on-expanding-collaboration-karolinska-institutet-for-rnai\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Phio Pharma +51% premarket on expanding collaboration with Karolinska Institutet for RNAi immunotherapies</a></h4><ul> <li>Phio Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PHIO' title='Phio Pharmaceuticals Corp.'>PHIO</a>) has <a href=\"https://seekingalpha.com/pr/17707032-phio-pharmaceuticals-karolinska-institutet-expand-collaboration-develop-self-delivering-rnai\" target=\"_blank\">expanded</a> its research collaboration with the Karolinska Institutet in Stockholm, Sweden.</li><li>Phio and Karolinska have agreed to extend and expand the collaboration to research aimed at decreasing immune-inhibitory factors in the tumor micro-environment and/or arming T cell, NK cell, dendritic cells and macrophages to overcome tumor immunosuppression utilizing Phio Pharmaceuticals' INTASYL platform.</li> <li>The focus of the expanded collaboration will include developing a pathway to the clinic and establishing the utility of Phio Pharmaceuticals' self-delivering RNAi in these therapeutic applications.</li> <li>Shares are up <font color=\"green\">51%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521152\" data-linked=\"Phio Pharma +51% premarket on expanding collaboration with Karolinska Institutet for RNAi immunotherapies\" data-tweet=\"$PHIO - Phio Pharma +51% premarket on expanding collaboration with Karolinska Institutet for RNAi immunotherapies https://seekingalpha.com/news/3521152-phio-pharmaplus-51-premarket-on-expanding-collaboration-karolinska-institutet-for-rnai?source=tweet\" data-url=\"https://seekingalpha.com/news/3521152-phio-pharmaplus-51-premarket-on-expanding-collaboration-karolinska-institutet-for-rnai\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521146\" data-ts=\"1574339963\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLAN\" target=\"_blank\">PLAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521146-anaplan-eps-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anaplan EPS beats by $0.05, beats on revenue</a></h4><ul><li>Anaplan (NYSE:<a href='https://seekingalpha.com/symbol/PLAN' title='Anaplan, Inc.'>PLAN</a>): Q3 Non-GAAP EPS of -$0.08 <font color=\"green\">beats by $0.05</font>; GAAP EPS of -$0.26 <font color=\"green\">beats by $0.06</font>.</li><li>Revenue of $89.41M (+44.2% Y/Y) <font color=\"green\">beats by $2.94M</font>.</li><li>Shares <font color=\"green\">+9.87%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17707037-anaplan-announces-third-quarter-fiscal-year-2020-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3521146\" data-linked=\"Anaplan EPS beats by $0.05, beats on revenue\" data-tweet=\"$PLAN - Anaplan EPS beats by $0.05, beats on revenue https://seekingalpha.com/news/3521146-anaplan-eps-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3521146-anaplan-eps-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521142\" data-ts=\"1574339753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTEM\" target=\"_blank\">MTEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521142-molecular-prices-common-and-preferred-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Molecular prices common and preferred share offering</a></h4><ul> <li>Molecular Templates (NASDAQ:<a href='https://seekingalpha.com/symbol/MTEM' title='Molecular Templates, Inc.'>MTEM</a>) <a href=\"https://seekingalpha.com/pr/17706984-molecular-templates-inc-announces-pricing-50_0-million-public-equity-offering\" target=\"_blank\">prices</a> its public offering of 6.0M common shares at $8.00 per share and 250 Series A convertible preferred shares at $8,000 per share, for expected gross proceeds of $50M.</li><li>Each share of Series A convertible preferred stock will be convertible into 1,000 common shares. Underwriters' over-allotment is an additional 900,000 common shares.</li><li>Closing date is November 25.</li>       <li>Net proceeds will be used to fund: ongoing clinical studies; further preclinical development and drug discovery activities and for working capital and general corporate purposes.</li><li>Shares are down <font color=\"red\">2%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3521005-molecular-launches-equity-offering-shares-6-percent-hours\" target=\"_blank\">Molecular launches equity offering; shares down 6% after hours</a> (Nov. 20)</li>            </ul><div class=\"tiny-share-widget\" data-id=\"3521142\" data-linked=\"Molecular prices common and preferred share offering\" data-tweet=\"$MTEM - Molecular prices common and preferred share offering https://seekingalpha.com/news/3521142-molecular-prices-common-and-preferred-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3521142-molecular-prices-common-and-preferred-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521141\" data-ts=\"1574339619\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUB\" target=\"_blank\">CUB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521141-jpmorgan-hits-cubic-sidelines-after-mixed-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan hits Cubic sidelines after mixed earnings</a></h4><ul><li>JPMorgan lowers Cubic (NYSE:<a href='https://seekingalpha.com/symbol/CUB' title='Cubic Corporation'>CUB</a>) from Overweight to Neutral and cuts the target from $78 to $67. The company has a Neutral <a href=\"https://seekingalpha.com/symbol/CUB/ratings/quant-ratings\" target=\"_blank\">Quant rating</a>.</li><li>The firm notes that CUB's FY20 outlook \"was lower than expected on an organic basis.\" Cubic is also missing its 2020 EBITDA targets due in part to increased investment activity.</li><li>JPMorgan is still optimistic on the company's long-term growth potential, but thinks shares will be range-bound until margin visibility improves.</li><li>Related: Yesterday, Cubic <a href=\"https://seekingalpha.com/news/3521030-cubic-minus-3_6-percent-profits-miss-despite-revenue-growth\" target=\"_blank\">reported</a> Q4 earnings that beat on revenue but missed on adjusted profits.</li><li>CUB shares are <font color=\"red\">down 16%</font> pre-market to $61.75.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521141\" data-linked=\"JPMorgan hits Cubic sidelines after mixed earnings\" data-tweet=\"$CUB - JPMorgan hits Cubic sidelines after mixed earnings https://seekingalpha.com/news/3521141-jpmorgan-hits-cubic-sidelines-after-mixed-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3521141-jpmorgan-hits-cubic-sidelines-after-mixed-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521139\" data-ts=\"1574339230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BJ\" target=\"_blank\">BJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521139-bjs-wholesale-club-nudges-higher-after-mixed-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BJ&#39;s Wholesale Club nudges higher after mixed quarter</a></h4><ul> <li>BJ's Wholesale Club (NYSE:<a href='https://seekingalpha.com/symbol/BJ' title='BJ&#39;s Wholesale Club Holdings, Inc.'>BJ</a>) reports comparable sales rose 1.1% (ex-fuel) in <a href=\"https://seekingalpha.com/pr/17706919-bj-s-wholesale-club-holdings-inc-announces-third-quarter-fiscal-2019-results\" target=\"_blank\">Q3</a> vs. +2.0% consensus.</li> <li>Adjusted EBITDA increased 3.8% to $154.1M during the quarter. Operating margin rose 30 bps to 3.1% of sales during the quarter.</li> <li>Looking ahead, the retailer anticipates full year sales of $12.9B vs. $12.9B to $13.2B consensus and adjusted EBITDA of $585M to $592M vs. $590M to $600M prior view and $585M consensus. EPS of $1.44 to $1.48 is anticipated vs. $1.42 to $1.50 prior view and $1.49 consensus.</li> <li>Shares of BJ's are <font color=\"green\">up 0.46%</font> premarket to $26.05 on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3521120-bj-s-wholesale-club-eps-beats-0_01-misses-revenue\" target=\"_blank\">BJ\u2019s Wholesale Club EPS beats by $0.01, misses on revenue</a> (Nov. 21)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521139\" data-linked=\"BJ&#39;s Wholesale Club nudges higher after mixed quarter\" data-tweet=\"$BJ - BJ&#39;s Wholesale Club nudges higher after mixed quarter https://seekingalpha.com/news/3521139-bjs-wholesale-club-nudges-higher-after-mixed-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3521139-bjs-wholesale-club-nudges-higher-after-mixed-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521138\" data-ts=\"1574338962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521138-amd-downgraded-on-valuation-sharesminus-1_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD downgraded on valuation; shares -1.4%</a></h4><ul><li>Northland Securities cuts AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) from Outperform to Market Perform with a $36 target, a 12% downside. The company has a Neutral average <a href=\"https://seekingalpha.com/symbol/AMD?s=amd\" target=\"_blank\">Sell Side rating</a>.</li><li>The firm says valuation has moved ahead of AMD's fundamentals.</li><li>Analyst Gus Richard writes that while shares will likely \"melt up between now and the end of the year, we would not be chasing them.\"</li><li>Richard says AMD's expanded market share this year, but \"incremental share gains get much more difficult\" due to Intel incumbency.</li><li>On Tuesday, AMD shares closed at the highest level in 13 years after the company <a href=\"https://seekingalpha.com/news/3520579-amd-launches-7nm-gpu-workstations-shares-plus-4-percent\" target=\"_blank\">launched</a> its 7nm GPU for workstations.</li><li>AMD shares are <font color=\"red\">down 1.4%</font> pre-market to $40.43.</li><li>Post updated with more details from the note.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521138\" data-linked=\"AMD downgraded on valuation; shares -1.4%\" data-tweet=\"$AMD - AMD downgraded on valuation; shares -1.4% https://seekingalpha.com/news/3521138-amd-downgraded-on-valuation-sharesminus-1_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3521138-amd-downgraded-on-valuation-sharesminus-1_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>195&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521130\" data-ts=\"1574338283\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521130-macysminus-5-after-guiding-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macy&#39;s -5% after guiding low</a></h4><ul> <li>Macy's (NYSE:<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s, Inc.'>M</a>) heads lower after the company <a href=\"https://seekingalpha.com/pr/17706932-macy-s-inc-reports-third-quarter-2019-earnings\" target=\"_blank\">sets</a> guidance below expectations.</li> <li>Macy's sees FY20 sales growth of -2.5% to -2.0% vs prior guidance for around flat growth and -0.5% consensus. FY20 EPS of $2.57 to $2.77 is anticipated vs. a prior view for $2.85 to $3.05 and $2.80 consensus.</li> <li>CEO update: \"Our third quarter sales were impacted by the late arrival of cold weather, continued soft international tourism and weaker than anticipated performance in lower tier malls. We also experienced a temporary impact on our e-commerce business due in part to work on the site in preparation for the fourth quarter.\"</li>  <li>Shares of Macy's are <font color=\"red\">down 4.88%</font> premarket to $14.30 and are now off more than 50% for the year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3521121-macys-eps-beats-0_08-misses-revenue\" target=\"_blank\">Macy's EPS beats by $0.08, misses on revenue</a> (Nov. 21)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3521130\" data-linked=\"Macy&#39;s -5% after guiding low\" data-tweet=\"$M - Macy&#39;s -5% after guiding low https://seekingalpha.com/news/3521130-macysminus-5-after-guiding-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3521130-macysminus-5-after-guiding-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>142&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521127\" data-ts=\"1574338176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BZUN\" target=\"_blank\">BZUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521127-baozunminus-12-after-misses-downside-q4-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baozun -12% after misses, downside Q4 view</a></h4><ul><li>Baozun (NASDAQ:<a href='https://seekingalpha.com/symbol/BZUN' title='Baozun Inc.'>BZUN</a>)<font color=\"red\"> slides 12.3%</font> after reporting <a href=\"https://seekingalpha.com/news/3521087-baozun-eps-misses-0_01-misses-revenue\" target=\"_blank\">Q3 misses</a> with downside Q4 guidance that sees revenue of RMB2.7-2.75B compared to the RMB2.84B consensus.</li><li>Q3 Services revenue was up 39% Y/Y to RMB840.8M. Product sales rose 31% to RMB662.3M.</li><li>Income from operations increased 24% to RMB75.9M.</li><li>Gross Merchandise Volume grew 43% to RMB9.1B.</li><li>Earnings call starts at 8 AM ET with a webcast <a href=\"https://www.globenewswire.com/Tracker?data=Ypw3Z5kh7ABlUo3efYmrCCVZvmFNQjVrLrZGSy2-Uu9HGwTx4ptASsGOwl1D9CRRIijqfPwqontA9JIwqQ0ulxH_IuV5i_8P99EUd5LCpyc=\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17706781-baozun-announces-third-quarter-2019-unaudited-financial-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3521127\" data-linked=\"Baozun -12% after misses, downside Q4 view\" data-tweet=\"$BZUN - Baozun -12% after misses, downside Q4 view https://seekingalpha.com/news/3521127-baozunminus-12-after-misses-downside-q4-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3521127-baozunminus-12-after-misses-downside-q4-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521111\" data-ts=\"1574334255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BV\" target=\"_blank\">BV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521111-brightview-holdings-eps-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BrightView Holdings EPS beats by $0.02, beats on revenue</a></h4><ul><li>BrightView Holdings (NYSE:<a href='https://seekingalpha.com/symbol/BV' title='BrightView Holdings, Inc.'>BV</a>): Q4 Non-GAAP EPS of $0.44 <font color=\"green\">beats by $0.02</font>; GAAP EPS of $0.24 <font color=\"red\">misses by $0.07</font>.</li><li>Revenue of $624.8M (+7.4% Y/Y) <font color=\"green\">beats by $3.43M</font>.</li><li>Shares <font color=\"green\">+7.9%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17706873-brightview-reports-fourth-quarter-full-year-fiscal-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3521111\" data-linked=\"BrightView Holdings EPS beats by $0.02, beats on revenue\" data-tweet=\"$BV - BrightView Holdings EPS beats by $0.02, beats on revenue https://seekingalpha.com/news/3521111-brightview-holdings-eps-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3521111-brightview-holdings-eps-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521105\" data-ts=\"1574333484\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCHW\" target=\"_blank\">SCHW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521105-td-ameritrade-soars-on-schwab-buyout-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TD Ameritrade soars on Schwab buyout report</a></h4><ul><li>Charles Schwab (NYSE:<a href='https://seekingalpha.com/symbol/SCHW' title='The Charles Schwab Corporation'>SCHW</a>) is in talks to buy TD Ameritrade (NASDAQ:<a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a>), according to <a href=\"https://www.cnbc.com/2019/11/21/charles-schwab-in-talks-to-buy-td-ameritrade-a-deal-could-be-announced-as-early-as-today-source-says.html\" target=\"_blank\">CNBC sources</a>, while Fox Business separately <a href=\"https://www.foxbusiness.com/markets/charles-schwab-buying-td-ameritrade-for-26b\" target=\"_blank\">reported</a> Schwab would pay $26B for the company.</li><li>The sector has been under recent pressure by the move to no-fee commissions, leaving brokerages scrambling to find ways to maintain profits.</li><li>Regulatory pressure? Schwab and TD Ameritrade are the two biggest publicly traded discount brokers and a tie-up would create a behemoth with $5T in combined assets.</li><li><a href='https://seekingalpha.com/symbol/SCHW' title='The Charles Schwab Corporation'>SCHW</a> <font color=\"red\">-2.3%</font>; <a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a> <font color=\"green\">+25.7%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3521105\" data-linked=\"TD Ameritrade soars on Schwab buyout report\" data-tweet=\"$SCHW $AMTD - TD Ameritrade soars on Schwab buyout report https://seekingalpha.com/news/3521105-td-ameritrade-soars-on-schwab-buyout-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3521105-td-ameritrade-soars-on-schwab-buyout-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>155&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3521094\" data-ts=\"1574328579\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3521094-seadrill-eps-misses-2_98-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill EPS misses by $2.98, beats on revenue</a></h4><ul><li>Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited'>SDRL</a>): Q3 GAAP EPS of -$5.21 <font color=\"red\">misses by $2.98</font>.</li><li>Revenue of $367M (+47.4% Y/Y) <font color=\"green\">beats by $54.32M</font>.</li><li>Shares <font color=\"green\">+6.6%</font> PM.</li><li><a href=\"https://ml-eu.globenewswire.com/Resource/Download/89591cf0-170a-4b78-8869-7585198ec7cf\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3521094\" data-linked=\"Seadrill EPS misses by $2.98, beats on revenue\" data-tweet=\"$SDRL - Seadrill EPS misses by $2.98, beats on revenue https://seekingalpha.com/news/3521094-seadrill-eps-misses-2_98-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3521094-seadrill-eps-misses-2_98-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":74,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}